<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Diabetologia via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Diabetologia' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Diabetologia&t=Diabetologia&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 15:08:54 +0100</lastBuildDate>
        <item>
            <title>Deploying insulin granule–granule fusion to rescue deficient insulin secretion in diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5667691&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff1471w64481n3754%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;According to our current understanding of insulin exocytosis, insulin granules dock on the plasma membrane, undergo priming
 and then wait for calcium-triggered fusion. In this issue of Diabetologia, Hoppa et al (doi 10.1007/s00125-011-2400-5) report that cholinergic stimulation induces granule–granule, or multivesicular, fusion to effect more efficient insulin
 release. Other exocytotic modes of insulin secretion, particularly those induced by incretin stimulation, include orderly
 granule fusion with granules already fused with the plasma membrane, called sequential exocytosis, and recruitment of newcomer
 granules to fuse with plasma membrane with minimal time for docking and priming. The molecular machineries that mediate these
 distinct exocytotic modes of granul...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667691</comments>
            <pubDate>Fri, 03 Feb 2012 17:11:34 +0100</pubDate>
            <guid isPermaLink="false">5667691</guid>        </item>
        <item>
            <title>Deletion of Fas protects islet beta cells from cytotoxic effects of human islet amyloid polypeptide</title>
            <link>http://www.medworm.com/index.php?rid=5667692&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr242037721717453%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;The aggregation of biosynthetic hIAPP produced in islets induces beta cell apoptosis, at least partially, via Fas upregulation
 and the Fas-mediated apoptotic pathway. Deletion of Fas protects islet beta cells from the cytotoxic effects of endogenously secreted (and exogenously applied) hIAPP.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-13DOI 10.1007/s00125-012-2451-2Authors
		Y. J. Park, Department of Surgery, Faculty of Medicine, University of British Columbia, Jim Pattison Pavilion, Vancouver General Hospital, 910 W 10th Ave, Vancouver, BC, Canada V5Z 4E3S. Lee, Department of Surgery, Faculty of Medicine, University of British Columbia, Jim Pattison Pavilion, Vancouver General Hospital, 910 W 10th Ave, Vancouver, BC, Canada V5Z 4E3T...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667692</comments>
            <pubDate>Thu, 02 Feb 2012 18:12:53 +0100</pubDate>
            <guid isPermaLink="false">5667692</guid>        </item>
        <item>
            <title>Impact of diabetes and glycaemic control on peripheral artery disease in Japanese patients with end-stage renal disease: long-term follow-up study from the beginning of haemodialysis</title>
            <link>http://www.medworm.com/index.php?rid=5667694&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8251h67v83762456%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Diabetes was a strong predictor of PAD after initiation of haemodialysis therapy in patients with ESRD. In addition, higher
 HbA1c levels were associated with increased risk of developing PAD and requiring limb amputation in such diabetic populations.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-6DOI 10.1007/s00125-012-2473-9Authors
		H. Ishii, Department of Cardiology, Nagoya University Graduate School of Medicine, 65, Tsurumai-cho, Showa-ku, Nagoya, 466-8550 JapanY. Kumada, Department of Cardiology, Nagoya Kyoritsu Hospital, Nagoya, JapanH. Takahashi, Department of Cardiology, Nagoya Kyoritsu Hospital, Nagoya, JapanT. Toriyama, Department of Cardiology, Nagoya Kyoritsu Hospital, Nagoya, JapanT. Aoyama, Department of Cardiology, Nagoya...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667694</comments>
            <pubDate>Thu, 02 Feb 2012 06:55:33 +0100</pubDate>
            <guid isPermaLink="false">5667694</guid>        </item>
        <item>
            <title>Is FTO a type 2 diabetes susceptibility gene?</title>
            <link>http://www.medworm.com/index.php?rid=5667693&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg2685xt7r738m873%2F</link>
            <description>Content Type Journal ArticleCategory CommentaryPages 1-4DOI 10.1007/s00125-012-2478-4Authors
		D. Meyre, Department of Clinical Epidemiology and Biostatistics, Michael DeGroote Centre for Learning &amp; Discovery, McMaster University, Room 3205, 1280 Main Street West, Hamilton, ON L8S 4L8, Canada
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia)</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667693</comments>
            <pubDate>Thu, 02 Feb 2012 06:55:33 +0100</pubDate>
            <guid isPermaLink="false">5667693</guid>        </item>
        <item>
            <title>Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: the HUNT study, Norway</title>
            <link>http://www.medworm.com/index.php?rid=5667695&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy77468x8543751r7%2F</link>
            <description>Conclusion/interpretation&amp;nbsp;&amp;nbsp;The pattern of antibodies, the postdiabetic loss or persistence as well as the prediabetic absence or presence of antibodies
 influence LADA phenotypes. Time-dependent presence or absence of antibodies adds new modalities to the heterogeneity of LADA.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-9DOI 10.1007/s00125-012-2463-yAuthors
		E. P. Sørgjerd, Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), HUNT Research Centre, Forskningsveien 2, 7600 Levanger, NorwayF. Skorpen, Department of Laboratory Medicine, Children’s and Women’s Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, NorwayK. Kvaløy, HUNT Research Centre,...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667695</comments>
            <pubDate>Thu, 02 Feb 2012 06:55:32 +0100</pubDate>
            <guid isPermaLink="false">5667695</guid>        </item>
        <item>
            <title>List of referees</title>
            <link>http://www.medworm.com/index.php?rid=5660399&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ffx7086h424653406%2F</link>
            <description>LIST OF REFEREES
	Content Type Journal ArticleCategory List of RefereeesPages 1-2DOI 10.1007/s00125-012-2470-z

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia)</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5660399</comments>
            <pubDate>Wed, 01 Feb 2012 17:13:41 +0100</pubDate>
            <guid isPermaLink="false">5660399</guid>        </item>
        <item>
            <title>Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5660400&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj177502j71564714%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The age period 9&amp;nbsp;months to 2&amp;nbsp;years is associated with a high incidence of activation of type 1 diabetes-associated autoimmunity
 in genetically at-risk children and should be targeted for effective primary prevention strategies.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-7DOI 10.1007/s00125-012-2472-xAuthors
		A.-G. Ziegler, Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstaedter Landstrasse 1, 85764 Neuherberg, GermanyE. Bonifacio, Forschergruppe Diabetes e.V. at Helmholtz Zentrum München, Neuherberg, Germanythe BABYDIAB-BABYDIET Study Group
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia)</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5660400</comments>
            <pubDate>Tue, 31 Jan 2012 07:12:31 +0100</pubDate>
            <guid isPermaLink="false">5660400</guid>        </item>
        <item>
            <title>Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus</title>
            <link>http://www.medworm.com/index.php?rid=5648770&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2u9h173087116lw5%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Among patients with type 2 diabetes, a higher resting heart rate is associated with an increased risk of death and cardiovascular
 complications. It remains unclear whether a higher heart rate directly mediates the increased risk or is a marker for other
 factors that determine a poor outcome.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-8DOI 10.1007/s00125-012-2471-yAuthors
		G. S. Hillis, The George Institute for Global Health, King George V Building, Royal Prince Alfred Hospital, Sydney, NSW 2050, AustraliaM. Woodward, The George Institute for Global Health, King George V Building, Royal Prince Alfred Hospital, Sydney, NSW 2050, AustraliaA. Rodgers, The George Institute for Global Health, King George V Building, Royal Prince Alfred H...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648770</comments>
            <pubDate>Sat, 28 Jan 2012 16:52:22 +0100</pubDate>
            <guid isPermaLink="false">5648770</guid>        </item>
        <item>
            <title>Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5648771&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fppvx8725782136k2%2F</link>
            <description>Conclusion/interpretation&amp;nbsp;&amp;nbsp;Insulin resistance and IGT, representing two stages in the path towards diabetes, are associated with differential reductions
 in the incretin effect seen before the development of IGT and overt type 2 diabetes. The reduction is unrelated to secretion
 of incretin hormones, but is related to insulin resistance and subtle beta cell defects, and is further aggravated on development
 of IGT.
 
 
 
 
 Trial registration:&amp;nbsp;&amp;nbsp;ClinicalTrials.gov NCT00784745.
 
 
 
 Funding:&amp;nbsp;&amp;nbsp;This study was supported by a grant from the Novo Nordisk Foundation.
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-012-2459-7Authors
		D. H. Jensen, Department of Endocrinology, Bispebjerg University Hospital, Bispebjerg Bakke 23, DK-240...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648771</comments>
            <pubDate>Sat, 28 Jan 2012 16:52:19 +0100</pubDate>
            <guid isPermaLink="false">5648771</guid>        </item>
        <item>
            <title>The Diabetes Excess Weight Loss (DEWL) Trial: a randomised controlled trial of high-protein versus high-carbohydrate diets over 2 years in type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5648772&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc5krn1t1104nuk3k%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;In a ‘real-world’ setting, prescription of an energy-reduced low-fat diet, with either increased protein or carbohydrate,
 results in similar modest losses in weight and waist circumference over 2&amp;nbsp;years.
 
 
 
 
 Trial registration:&amp;nbsp;&amp;nbsp;Australia New Zealand Clinical Trials Register ACTRN12606000490572
 
 
 
 Funding:&amp;nbsp;&amp;nbsp;The Health Research Council of New Zealand (06/337).
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-012-2461-0Authors
		J. D. Krebs, Department of Medicine, University of Otago, Wellington, New ZealandC. R. Elley, School of Population Health, University of Auckland, Auckland, New ZealandA. Parry-Strong, Department of Medicine, University of Otago, Wellington, New ZealandH. Lunt, ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648772</comments>
            <pubDate>Sat, 28 Jan 2012 06:42:35 +0100</pubDate>
            <guid isPermaLink="false">5648772</guid>        </item>
        <item>
            <title>Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans</title>
            <link>http://www.medworm.com/index.php?rid=5648773&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl1137321j0213241%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;In conclusion, pancreatic diabetes probably develops after a reduction in beta cell area of ~65%. Post-challenge glucose excursions
 are much more closely related to pancreatic beta cell area than to fasting glycaemia, thereby underlining the usefulness of
 the OGTT in patients with pancreatic disorders.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-9DOI 10.1007/s00125-012-2466-8Authors
		J. J. Meier, Diabetes Division, Department of Medicine I, St Josef Hospital, Ruhr University Bochum, Gudrunstr. 56, 44791 Bochum, GermanyT. G. K. Breuer, Diabetes Division, Department of Medicine I, St Josef Hospital, Ruhr University Bochum, Gudrunstr. 56, 44791 Bochum, GermanyR. C. Bonadonna, Department of Medicine, Division of Endocrinology and Metabo...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648773</comments>
            <pubDate>Fri, 27 Jan 2012 17:56:33 +0100</pubDate>
            <guid isPermaLink="false">5648773</guid>        </item>
        <item>
            <title>The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes</title>
            <link>http://www.medworm.com/index.php?rid=5648776&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe6443xu777m05841%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Our data suggest that increased glycolytic and decreased mitochondrial protein abundance together with a shift in muscle properties
 towards a fast-twitch pattern in the absence of marked changes in fibre-type distribution contribute to insulin resistance
 in obesity with and without type 2 diabetes. The roles of several differentially expressed or post-translationally modified
 proteins remain to be elucidated.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-14DOI 10.1007/s00125-012-2456-xAuthors
		J. Giebelstein, Medizinische Klinik I, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Klinikum der Ruhr Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789 Bochum, GermanyG. Poschmann, Medizinisches Proteom-Center, Ruhr Univ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648776</comments>
            <pubDate>Thu, 26 Jan 2012 16:44:55 +0100</pubDate>
            <guid isPermaLink="false">5648776</guid>        </item>
        <item>
            <title>Contractile activity of human skeletal muscle cells prevents insulin resistance by inhibiting pro-inflammatory signalling pathways</title>
            <link>http://www.medworm.com/index.php?rid=5648775&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx062187r38111730%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;We showed that the effects of electrical pulse stimulation on skeletal muscle cells were similar to the effect of exercise
 on skeletal muscle in vivo in terms of enhanced AMPK activation and IL-6 secretion. In our model, muscle contractile activity
 eliminates insulin resistance by blocking pro-inflammatory signalling pathways. This novel model therefore provides a unique
 tool for investigating the molecular mechanisms that mediate the beneficial effects of muscle contraction.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-12DOI 10.1007/s00125-012-2454-zAuthors
		S. Lambernd, Paul-Langerhans-Group, Integrative Physiology, German Diabetes Center, Auf´m Hennekamp 65, 40225 Duesseldorf, GermanyA. Taube, Paul-Langerhans-Group, Integrative ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648775</comments>
            <pubDate>Thu, 26 Jan 2012 16:44:55 +0100</pubDate>
            <guid isPermaLink="false">5648775</guid>        </item>
        <item>
            <title>Complement C3: an emerging risk factor in cardiometabolic disease</title>
            <link>http://www.medworm.com/index.php?rid=5648774&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff61k0722860530t8%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;C3 is the central component of the complement system and activation of C3 via any of the three major activation pathways—the
 classical, the lectin and the alternative pathways—results in initiation of the terminal complement pathway and release of
 the anaphylatoxin C3a. Both terminal pathway activation and signalling of C3a and its inactivation product C3a-desarg via
 the C3a receptor and C5a-like receptor 2, respectively, can induce inflammatory, immunomodulatory and metabolic responses.
 C3 has been implicated in metabolic disorders, notably adiposity, dyslipidaemia, insulin resistance, liver dysfunction and
 diabetes, and C3 is increasingly recognised as a cardiometabolic risk factor. C3 may play a role in the macrovascular, as
 well as microvascular, complicat...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648774</comments>
            <pubDate>Thu, 26 Jan 2012 16:44:55 +0100</pubDate>
            <guid isPermaLink="false">5648774</guid>        </item>
        <item>
            <title>Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials</title>
            <link>http://www.medworm.com/index.php?rid=5648777&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft1712k67n64641kr%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Weight loss is safe, and improves liver histology and cardio-metabolic profile. For patients not responding to lifestyle intervention,
 pioglitazone improves histological disease activity, slows fibrosis progression and extensively ameliorates cardio-metabolic
 endpoints. Further randomised controlled trials (RCTs) of adequate size and duration will assess long-term safety and efficacy
 of proposed treatments on clinical outcomes.
 
 
 
 
	Content Type Journal ArticleCategory Systematic reviewPages 1-20DOI 10.1007/s00125-011-2446-4Authors
		G. Musso, Gradenigo Hospital, C.so Regina Margherita 8, 10132 Turin, ItalyM. Cassader, Department of Internal Medicine, University of Turin, Turin, ItalyF. Rosina, Gradenigo Hospital, C.so Regina Margherita 8, 10132...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648777</comments>
            <pubDate>Thu, 26 Jan 2012 06:44:13 +0100</pubDate>
            <guid isPermaLink="false">5648777</guid>        </item>
        <item>
            <title>Confirmation of novel type 1 diabetes risk loci in families</title>
            <link>http://www.medworm.com/index.php?rid=5648778&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg1g558u40t582k4h%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;The results for the novel GWA study-identified loci are genuine and not due to population stratification. The next step, namely
 correlation of the most disease-associated genotypes with phenotypes, such as RNA and protein expression analyses for the
 candidate genes within or near each of the susceptibility regions, can now proceed.
 
 
 
 
	Content Type Journal ArticleCategory Short CommunicationPages 1-5DOI 10.1007/s00125-012-2450-3Authors
		J. D. Cooper, Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke’s Hospital, Cambridge, CB2 0YX UKJ. M. M. Howson, Juvenile Diabetes Research Foundation/Wellcom...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648778</comments>
            <pubDate>Wed, 25 Jan 2012 18:08:14 +0100</pubDate>
            <guid isPermaLink="false">5648778</guid>        </item>
        <item>
            <title>Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates?</title>
            <link>http://www.medworm.com/index.php?rid=5638933&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F223xx0777x422783%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Diabetic patients can be characterised by an increased formation of TPINT and MG. The 25-fold increase of MG in type 1 and the 15-fold increase in type 2 diabetes, together with a several-fold increase
 in TPINT and decreased glyceraldehyde-3-phosphate dehydrogenase activity even under normal glucose conditions, imply that normalising
 glucose level cannot completely prevent late diabetic complications until this acquired error of metabolism has been restored.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-5DOI 10.1007/s00125-012-2452-1Authors
		T. Fleming, Department of Medicine I and Clinical Chemistry, University of Heidelberg, INF 410, 69120 Heidelberg, GermanyJ. Cuny, Department of Medicine I and Clinical Chemistry, University of Hei...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638933</comments>
            <pubDate>Tue, 24 Jan 2012 07:29:37 +0100</pubDate>
            <guid isPermaLink="false">5638933</guid>        </item>
        <item>
            <title>What’s new since Hippocrates? Preventing type 2 diabetes by physical exercise and diet</title>
            <link>http://www.medworm.com/index.php?rid=5638932&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fan8246211432273l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Since the work of Eriksson and Lindgärde, published over two decades ago (Diabetologia 1991;34:891–898), we have known that type 2 diabetes can be prevented or delayed by supervised lifestyle interventions (physical
 exercise and diet modification) in persons at risk of the disease. Here we discuss a novel, time-efficient approach to physical
 exercise prescription, low-volume, high-intensity interval training (LVHIT), and its efficacy for inducing a range of health
 benefits in a variety of populations at risk of inactivity-related diseases. We look to the future and suggest that current
 guidelines for exercise may need to be revised to include different training techniques to deliver the optimum exercise prescription.
 Indeed, we predict that subsequent exercise g...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638932</comments>
            <pubDate>Tue, 24 Jan 2012 07:29:37 +0100</pubDate>
            <guid isPermaLink="false">5638932</guid>        </item>
        <item>
            <title>Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring</title>
            <link>http://www.medworm.com/index.php?rid=5638934&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9th2670022m743v8%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;No difference was found in serum 25(OH)D concentrations during first trimester of pregnancy between mothers whose children
 later on developed type 1 diabetes, and mothers of non-diabetic ‘ healthy’ children of the same age. It is difficult to detect
 possible effects of mothers’ vitamin D deficiency during early pregnancy on the development of type 1 diabetes in the offspring
 in this population, as such a large proportion of mothers were vitamin D-deficient or -insufficient.
 
 
 
 
	Content Type Journal ArticleCategory Short CommunicationPages 1-4DOI 10.1007/s00125-012-2458-8Authors
		M. E. Miettinen, Department of Public Health, University of Helsinki, Helsinki, FinlandL. Reinert, Diabetes Prevention Unit, National Institute for Health and We...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638934</comments>
            <pubDate>Tue, 24 Jan 2012 07:29:36 +0100</pubDate>
            <guid isPermaLink="false">5638934</guid>        </item>
        <item>
            <title>Mesenchymal stem cells differentially mediate regulatory T cells and conventional effector T cells to protect fully allogeneic islet grafts in mice</title>
            <link>http://www.medworm.com/index.php?rid=5638935&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fqjl3718653044133%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;We demonstrate that MSCs are capable of regulating Teff and Treg cells differentially in vitro. MSCs inhibit Teff cells by inducing apoptosis and impairing the proliferative response to IL-2 in Teff cells, but favour the survival and expansion of Treg cells. This result is further demonstrated in mice that have undergone allogeneic islet transplantation, in which MSCs suppress
 alloreactive Teff cells while favouring the induction of Treg cells, thus protecting the islet allografts from rejection.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-12DOI 10.1007/s00125-011-2433-9Authors
		D. M. Xu, Department of Haematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republi...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638935</comments>
            <pubDate>Tue, 24 Jan 2012 07:29:35 +0100</pubDate>
            <guid isPermaLink="false">5638935</guid>        </item>
        <item>
            <title>Endothelial dysfunction in type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5620661&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmnqm523q1564m872%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The mechanisms responsible for the accelerated atherosclerosis observed in type 2 diabetes are not fully understood. One of
 the earliest events in the development of atherosclerosis is endothelial dysfunction, namely, a reduction in nitric oxide
 (NO) synthesis or its bioavailability within the peri-endothelial environment, where it is responsible for maintenance of
 vascular tissue integrity. The clinical evaluation of this pathway is hampered by the fact that in vivo NO cannot be directly
 measured; however, exploiting a novel, complex and elegant experimental setup, McVeigh and co-workers (Diabetologia
 1992;35:771–776) were the first to document that NO bioavailability in type 2 diabetic patients is indeed reduced. In this edition
 of ‘Then and now’ that pape...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620661</comments>
            <pubDate>Fri, 20 Jan 2012 07:03:08 +0100</pubDate>
            <guid isPermaLink="false">5620661</guid>        </item>
        <item>
            <title>Visual sensitivity loss in the central 30° of visual field is associated with diabetic peripheral neuropathy</title>
            <link>http://www.medworm.com/index.php?rid=5620662&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F32g20118605j567q%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Visual sensitivity reduces disproportionately with increasing eccentricity in type 2 diabetic patients with peripheral neuropathy.
 This sensitivity reduction within the central 30° of visual field may be indicative of more consequential loss in the far
 periphery.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-7DOI 10.1007/s00125-012-2457-9Authors
		G. P. Sampson, School of Optometry and Vision Science and Institute of Health and Biomedical Innovation, Queensland University of Technology, 60 Musk Avenue, Kelvin Grove, 4059 QLD, AustraliaA. M. Shahidi, School of Optometry and Vision Science and Institute of Health and Biomedical Innovation, Queensland University of Technology, 60 Musk Avenue, Kelvin Grove, 4059 QLD, AustraliaD. Vagenas, ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620662</comments>
            <pubDate>Thu, 19 Jan 2012 06:53:41 +0100</pubDate>
            <guid isPermaLink="false">5620662</guid>        </item>
        <item>
            <title>Clinical dyslipidaemia is associated with changes in the lipid composition and inflammatory properties of apolipoprotein-B-containing lipoproteins from women with type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5620664&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl17t27kv15676003%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;We showed that dyslipidaemia is associated with major changes in both lipid class and lipid species composition in VLDL and
 LDL from women with type 2 diabetes. In addition, we identified specific molecular lipid species that both correlate with
 clinical variables and are proinflammatory. Our study thus shows the potential of advanced lipidomic methods to further understand
 the pathophysiology of type 2 diabetes.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2444-6Authors
		M. Ståhlman, Sahlgrenska Centre for Cardiovascular and Metabolic Research/Wallenberg Laboratory and Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital, S-413 45 Gothenburg, SwedenH. T. Pham, School of Chemistry, University of ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620664</comments>
            <pubDate>Wed, 18 Jan 2012 06:51:44 +0100</pubDate>
            <guid isPermaLink="false">5620664</guid>        </item>
        <item>
            <title>Localisation and composition of skeletal muscle diacylglycerol predicts insulin resistance in humans</title>
            <link>http://www.medworm.com/index.php?rid=5620663&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F560111j44n531411%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;These data indicate that both cellular localisation and composition of DAG influence the relationship to insulin sensitivity.
 Our results suggest that only saturated DAG in skeletal muscle membranes are related to insulin resistance in humans.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2419-7Authors
		B. C. Bergman, Division of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, 12801 E. 17th Ave, PO Box 6511, MS 8106, Aurora, CO 80045, USAD. M. Hunerdosse, Division of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, 12801 E. 17th Ave, PO Box 6511, MS 8106, Aurora, CO 80045, USAA. Kerege, Division of Endocrinology, Metabolism, and Di...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620663</comments>
            <pubDate>Wed, 18 Jan 2012 06:51:44 +0100</pubDate>
            <guid isPermaLink="false">5620663</guid>        </item>
        <item>
            <title>Mice expressing a human KATP channel mutation have altered channel ATP sensitivity but no cardiac abnormalities</title>
            <link>http://www.medworm.com/index.php?rid=5620667&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft21151273511m06n%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;The common iDEND mutation Kir6.2-V59M decreases ATP block of cardiac KATP channels but was without obvious effect on heart function, suggesting that metabolic changes fail to open the mutated channel
 to an extent that affects function (at least in the absence of ischaemia). This may have implications for the choice of sulfonylurea
 used to treat neonatal diabetes.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2428-6Authors
		R. Clark, Henry Wellcome Centre for Gene Function, Department of Physiology, Anatomy and Genetics, Parks Road, Oxford, OX1 3PT UKR. Männikkö, Henry Wellcome Centre for Gene Function, Department of Physiology, Anatomy and Genetics, Parks Road, Oxford, OX1 3PT UKD. J. Stuckey, Henry Wellcome...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620667</comments>
            <pubDate>Wed, 18 Jan 2012 06:51:41 +0100</pubDate>
            <guid isPermaLink="false">5620667</guid>        </item>
        <item>
            <title>Novel standards in the measurement of rat insulin granules combining electron microscopy, high-content image analysis and in silico modelling</title>
            <link>http://www.medworm.com/index.php?rid=5620666&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3l8w35647710054q%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;A major reason for the lower mean granule number/rat beta cell relative to previous accounts is a reduced estimation of the
 mean beta cell volume. These findings imply that each granule contains about twofold more insulin, while its exocytosis increases
 membrane capacitance about twofold less than assumed previously. Our integrated approach defines new standards for quantitative
 image analysis of beta cells and could be applied to other cellular systems.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2438-4Authors
		E. Fava, Max Planck Institute for Molecular Cell Biology and Genetics, Dresden, GermanyJ. Dehghany, Department of Systems Immunology, Helmholtz Centre for Infection Research (HZI), Inhoffenstr. 7, 3...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620666</comments>
            <pubDate>Wed, 18 Jan 2012 06:51:41 +0100</pubDate>
            <guid isPermaLink="false">5620666</guid>        </item>
        <item>
            <title>Erratum to: Increased metabolic rate and insulin sensitivity in male mice lacking the carcino-embryonic antigen-related cell adhesion molecule 2</title>
            <link>http://www.medworm.com/index.php?rid=5620665&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb34t8q7204655501%2F</link>
            <description>Content Type Journal ArticleCategory ErratumPages 1-1DOI 10.1007/s00125-012-2453-0Authors
		P. R. Patel, Center for Diabetes and Endocrine Research, College of Medicine and Life Sciences, University of Toledo, Health Science Campus, 3000 Arlington Avenue, Mail Stop 1009, Toledo, OH 43614, USAS. K. Ramakrishnan, Center for Diabetes and Endocrine Research, College of Medicine and Life Sciences, University of Toledo, Health Science Campus, 3000 Arlington Avenue, Mail Stop 1009, Toledo, OH 43614, USAM. K. Kaw, Center for Diabetes and Endocrine Research, College of Medicine and Life Sciences, University of Toledo, Health Science Campus, 3000 Arlington Avenue, Mail Stop 1009, Toledo, OH 43614, USAC. K. Raphael, Center for Diabetes and Endocrine Research, College of Medicine and Life Sciences, ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620665</comments>
            <pubDate>Wed, 18 Jan 2012 06:51:41 +0100</pubDate>
            <guid isPermaLink="false">5620665</guid>        </item>
        <item>
            <title>Nano-scale encapsulation enhances allograft survival and function of islets transplanted in a mouse model of diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5598389&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fev58w3r534648205%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Nano-scale encapsulation offers localised immune protection for implanted islets, and may be able to limit early allograft
 loss and extend survival of transplanted islets. This versatile coating scheme has the potential to be integrated with tolerance
 induction mechanisms, thereby achieving long-term success in islet transplantation.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2431-yAuthors
		Z.-l. Zhi, Diabetes Research Group, King’s College London School of Medicine, Guy’s Hospital Campus, London, SE1 1UL UKA. Kerby, Diabetes Research Group, King’s College London School of Medicine, Guy’s Hospital Campus, London, SE1 1UL UKA. J. F. King, Diabetes Research Group, King’s College London School of Med...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5598389</comments>
            <pubDate>Sat, 14 Jan 2012 06:54:48 +0100</pubDate>
            <guid isPermaLink="false">5598389</guid>        </item>
        <item>
            <title>Involvement of thioredoxin-interacting protein (TXNIP) in glucocorticoid-mediated beta cell death</title>
            <link>http://www.medworm.com/index.php?rid=5598390&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6467114755hr3669%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Altogether, our data suggest TXNIP as a novel mediator of GC-induced apoptosis in beta cells and further contribute to our
 understanding of beta cell death pathways.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2422-zAuthors
		E. Reich, Department of Endocrinology, Hadassah University Hospital, PO Box 12 000, 91120 Jerusalem, IsraelA. Tamary, Department of Endocrinology, Hadassah University Hospital, PO Box 12 000, 91120 Jerusalem, IsraelR. Vogt Sionov, Department of Endocrinology, Hadassah University Hospital, PO Box 12 000, 91120 Jerusalem, IsraelD. Melloul, Department of Endocrinology, Hadassah University Hospital, PO Box 12 000, 91120 Jerusalem, Israel
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print I...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5598390</comments>
            <pubDate>Sat, 14 Jan 2012 06:54:47 +0100</pubDate>
            <guid isPermaLink="false">5598390</guid>        </item>
        <item>
            <title>Measures of health-related quality of life in diabetes-related foot disease: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=5598391&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F508937335r381516%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;No one PROM was identified as a ‘gold standard’ for assessing HRQOL in diabetes-related foot disease. Specific areas for further
 development include the most valid HRQOL PROM with disease-specific content; HRQOL outcomes in minor and major amputations
 and the role of HRQOL tools in routine clinical care.
 
 
 
 
	Content Type Journal ArticleCategory Systematic reviewPages 1-14DOI 10.1007/s00125-011-2372-5Authors
		F. R. A. Hogg, St George’s Vascular Institute, St James Wing, St George’s Healthcare NHS Trust, 4th Floor, Blackshaw Road, London, SW17 0QT UKG. Peach, St George’s Vascular Institute, St James Wing, St George’s Healthcare NHS Trust, 4th Floor, Blackshaw Road, London, SW17 0QT UKP. Price, School of Healthcare Studies, Cardiff Uni...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5598391</comments>
            <pubDate>Sat, 14 Jan 2012 06:54:45 +0100</pubDate>
            <guid isPermaLink="false">5598391</guid>        </item>
        <item>
            <title>Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety</title>
            <link>http://www.medworm.com/index.php?rid=5598393&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2up3217407g37072%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Infusion of exenatide in male type 2 diabetic patients with CHF increased the CI as a result of chronotropy, with concomitant
 favourable effects on PCWP and reasonable tolerability of the drug. The clinical implications of using exenatide in patients
 with CHF are still not clear and further studies are warranted.
 
 
 
 
 Trial registration:&amp;nbsp;&amp;nbsp;
 www.isrctn.org/ISRCTN47533126
 
 
 
 
 
 Funding:&amp;nbsp;&amp;nbsp;This study was funded through the regional agreement on medical training and clinical research (ALF) between Stockholm County
 Council and the Karolinska Institute, by the Swedish Society for Medical Research, the Swedish Society of Medicine, Stiftelsen
 Serafimerlasarettet, the Swedish Heart and Lung foundation, Eli Lilly Amylin Alliance, ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5598393</comments>
            <pubDate>Fri, 13 Jan 2012 16:55:51 +0100</pubDate>
            <guid isPermaLink="false">5598393</guid>        </item>
        <item>
            <title>Effect of exercise training on insulin sensitivity, mitochondria and computed tomography muscle attenuation in overweight women with and without polycystic ovary syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5598392&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F313g6g4625029hw6%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Differences in IR in women with and without PCOS were not explained by differences in skeletal muscle lipid or mitochondrial
 parameters. Improvements in IR with exercise were dissociated from mitochondrial parameters. CT muscle attenuation suggested
 a differential capacity of PCOS muscle to store lipid compared with non-PCOS.
 
 
 
 
 Trial registration:&amp;nbsp;&amp;nbsp;Clinicaltrials.gov ISRCTN84763265
 
 
 
 Funding:&amp;nbsp;&amp;nbsp;National Health &amp; Medical Research Council (Grant number 606553), Monash University and The Jean Hailes Foundation.
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2442-8Authors
		S. K. Hutchison, Jean Hailes Foundation Research, School of Public Health and Preventative Medicine, Monash Univers...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5598392</comments>
            <pubDate>Fri, 13 Jan 2012 16:55:51 +0100</pubDate>
            <guid isPermaLink="false">5598392</guid>        </item>
        <item>
            <title>How the immunoassay transformed C-peptide from a duckling into a swan</title>
            <link>http://www.medworm.com/index.php?rid=5598394&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh0897x4541619001%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This edition of ‘Then and now’ re-examines Lise Heding’s very highly cited paper ‘Radioimmunological determination of human
 C-peptide in serum’, which was published in Diabetologia in 1975. We show how this article and other related articles by Heding contributed to heightened respect for C-peptide (and
 transformation of Heding’s research programme). Initially thought of as an inert discard, C-peptide in blood is now recognised
 as an excellent surrogate measure of insulin secretion under a wide range of conditions. The assay is especially valuable
 for acute ascertainment of the insulin secretory capabilities of patients with type 1 diabetes or of transplanted beta cells.
 The assay is also being used to monitor endogenous beta cell loss or in vivo expans...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5598394</comments>
            <pubDate>Fri, 13 Jan 2012 16:55:48 +0100</pubDate>
            <guid isPermaLink="false">5598394</guid>        </item>
        <item>
            <title>A step closer to making beta cells</title>
            <link>http://www.medworm.com/index.php?rid=5598395&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg81145470x341489%2F</link>
            <description>Content Type Journal ArticleCategory CommentaryPages 1-2DOI 10.1007/s00125-011-2449-1Authors
		P. Serup, Department of Developmental Biology, Hagedorn Research Institute, Niels Steensens Vej 6, DK-2820 Gentofte, Denmark
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia)</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5598395</comments>
            <pubDate>Fri, 13 Jan 2012 16:55:46 +0100</pubDate>
            <guid isPermaLink="false">5598395</guid>        </item>
        <item>
            <title>Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study</title>
            <link>http://www.medworm.com/index.php?rid=5598396&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb8r722720xjm6743%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Treatment with Alo and Alo/Pio produced significant reductions in postprandial TG and TG-rich lipoproteins, contributing to
 an improved overall cardiometabolic risk profile in type 2 diabetes. The data support the concept that incretins not only
 modulate glucose metabolism but also influence chylomicron metabolism in intestinal cells.
 
 
 
 
 Trial registration:&amp;nbsp;&amp;nbsp;ClinicalTrials.gov number NCT00655863.
 
 
 
 Funding:&amp;nbsp;&amp;nbsp;The study was funded by Takeda Global Research &amp; Development.
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2447-3Authors
		B. Eliasson, Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sah...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5598396</comments>
            <pubDate>Thu, 12 Jan 2012 06:42:49 +0100</pubDate>
            <guid isPermaLink="false">5598396</guid>        </item>
        <item>
            <title>Deletion of C/EBP homologous protein (Chop) in C57Bl/6 mice dissociates obesity from insulin resistance</title>
            <link>http://www.medworm.com/index.php?rid=5582816&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1342v46x1h743880%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;These observations suggest that insulin resistance is not induced by fat accumulation per se, but rather by the inflammation
 induced by ectopic fat. CHOP may play a key role in the crosstalk between excessive fat deposition and induction of inflammation-mediated
 insulin resistance.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-12DOI 10.1007/s00125-011-2427-7Authors
		M. Maris, Laboratory for Experimental Medicine and Endocrinology (LEGENDO), Catholic University of Leuven, Herestraat 49 bus 902, 3000 Leuven, BelgiumL. Overbergh, Laboratory for Experimental Medicine and Endocrinology (LEGENDO), Catholic University of Leuven, Herestraat 49 bus 902, 3000 Leuven, BelgiumC. Gysemans, Laboratory for Experimental Medicine and Endocrinology (LE...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582816</comments>
            <pubDate>Wed, 11 Jan 2012 17:54:03 +0100</pubDate>
            <guid isPermaLink="false">5582816</guid>        </item>
        <item>
            <title>How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? Twelve year follow-up of the Ely cohort</title>
            <link>http://www.medworm.com/index.php?rid=5582817&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg33944x71u470613%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Diabetes screening resulted in cases being identified on average 3.3&amp;nbsp;years earlier, a difference significantly shorter than
 previous estimates. Earlier diagnosis did not appear to impact on health outcomes. Further evidence is needed to justify the
 introduction of population-based screening.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-9DOI 10.1007/s00125-011-2441-9Authors
		M. Rahman, General Practice and Primary Care Research Unit, University of Cambridge, Cambridge, UKR. K. Simmons, MRC Epidemiology Unit, Institute of Metabolic Science, Box 285, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 0QQ UKS. H. Hennings, MRC Epidemiology Unit, Institute of Metabolic Science, Box 285, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 0QQ UKN...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582817</comments>
            <pubDate>Wed, 11 Jan 2012 17:54:02 +0100</pubDate>
            <guid isPermaLink="false">5582817</guid>        </item>
        <item>
            <title>Impact of maternal diabetes on birthweight is greater in non-Hispanic blacks than in non-Hispanic whites</title>
            <link>http://www.medworm.com/index.php?rid=5582821&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fex392761n0413507%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;These data suggest that the negative effects of GDM combined with obesity during pregnancy may be greater in NHB than in NHW
 individuals.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2430-zAuthors
		K. J. Hunt, Department of Medicine/Biostatistics and Epidemiology, Medical University of South Carolina, 135 Cannon Street, Suite 302, P.O. Box 250835, Charleston, SC 29425, USAN. M. Marlow, Department of Medicine/Biostatistics and Epidemiology, Medical University of South Carolina, 135 Cannon Street, Suite 302, P.O. Box 250835, Charleston, SC 29425, USAM. Gebregziabher, Department of Medicine/Biostatistics and Epidemiology, Medical University of South Carolina, 135 Cannon Street, Suite 302, P.O. Box 250835, Charles...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582821</comments>
            <pubDate>Wed, 11 Jan 2012 17:54:00 +0100</pubDate>
            <guid isPermaLink="false">5582821</guid>        </item>
        <item>
            <title>Request for clarification from Ruiter et al regarding ‘Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’. Reply to Carstensen B [letter]</title>
            <link>http://www.medworm.com/index.php?rid=5582820&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn863g24pr4880377%2F</link>
            <description>Content Type Journal ArticleCategory LetterPages 1-2DOI 10.1007/s00125-011-2448-2Authors
		R. Ruiter, Department of Epidemiology, Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, the NetherlandsL. E. Visser, Department of Epidemiology, Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, the NetherlandsB. H. Ch. Stricker, Department of Epidemiology, Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia)</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582820</comments>
            <pubDate>Wed, 11 Jan 2012 17:54:00 +0100</pubDate>
            <guid isPermaLink="false">5582820</guid>        </item>
        <item>
            <title>Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly</title>
            <link>http://www.medworm.com/index.php?rid=5582819&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx00181644w50w501%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases
 serum IGF-I bioactivity in a similar manner.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-9DOI 10.1007/s00125-011-2435-7Authors
		A. J. Varewijck, Department of Internal Medicine, Division of Endocrinology, Erasmus MC, ‘s-Gravendijkwal 230, 3015 CE Rotterdam, the NetherlandsJ. A. M. J. L. Janssen, Department of Internal Medicine, Division of Endocrinology, Erasmus MC, ‘s-Gravendijkwal 230, 3015 CE Rotterdam, the NetherlandsM. Vähätalo, City of Turku Health Centre, Turku, FinlandL. J. Hofland, Department of Internal Medicine, Division of Endocrinology, Erasmus MC, ‘s-Gravendijkwal 230, 3015 CE Rotterdam, t...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582819</comments>
            <pubDate>Wed, 11 Jan 2012 17:54:00 +0100</pubDate>
            <guid isPermaLink="false">5582819</guid>        </item>
        <item>
            <title>Hedgehog signals inhibit postnatal beta cell neogenesis from adult rat exocrine pancreas in vitro</title>
            <link>http://www.medworm.com/index.php?rid=5582818&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp362r471xm915613%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;We report here Dhh/Ihh-dependent activation of hedgehog targets during pancreatic exocrine cell metaplasia in vitro and a persistent inhibitory
 function of hedgehog signalling in a model of postnatal beta cell differentiation.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2434-8Authors
		J. K. Mfopou, Cell Differentiation Unit, Diabetes Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, BelgiumL. Baeyens, Cell Differentiation Unit, Diabetes Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, BelgiumL. Bouwens, Cell Differentiation Unit, Diabetes Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium
	

	
		Journ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582818</comments>
            <pubDate>Wed, 11 Jan 2012 17:54:00 +0100</pubDate>
            <guid isPermaLink="false">5582818</guid>        </item>
        <item>
            <title>Chronic treatment with a glucokinase activator delays the onset of hyperglycaemia and preserves beta cell mass in the Zucker diabetic fatty rat</title>
            <link>http://www.medworm.com/index.php?rid=5582823&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff761425l02w3v823%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;These findings suggest that chronic activation of glucokinase preserves beta cell mass and delays disease in the ZDF rat,
 a model of insulin resistance and progressive beta cell failure.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2439-3Authors
		M. Futamura, Banyu Tsukuba Research Institute, MSD K.K., 3 Okubo, Tsukuba, Ibaraki 300-26, JapanJ. Yao, Departments of Metabolic Disorders and Pharmacology, Merck Sharp &amp; Dohme Corp., Whitehouse Station, NJ 0889, USAX. Li, Departments of Metabolic Disorders and Pharmacology, Merck Sharp &amp; Dohme Corp., Whitehouse Station, NJ 0889, USAR. Bergeron, Departments of Metabolic Disorders and Pharmacology, Merck Sharp &amp; Dohme Corp., Whitehouse Station, NJ 0889, USAJ.-L. Tran, ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582823</comments>
            <pubDate>Wed, 11 Jan 2012 06:55:41 +0100</pubDate>
            <guid isPermaLink="false">5582823</guid>        </item>
        <item>
            <title>Relationship of exercise volume to improvements of quality of life with supervised exercise training in patients with type 2 diabetes in a randomised controlled trial: the Italian Diabetes and Exercise Study (IDES)</title>
            <link>http://www.medworm.com/index.php?rid=5582822&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy15462p42177u04r%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;This large trial shows a relationship between changes in physical and mental health-related QoL measures and volume of physical
 activity/exercise, with supervised exercise training also providing volume-independent benefits.
 
 
 
 
 Trial registration:&amp;nbsp;&amp;nbsp;ISRCTN-04252749
 
 
 
 Funding:&amp;nbsp;&amp;nbsp;The study was funded by Lifescan SrL, Novo Nordisk Ltd, Bristol Myers Squibb Italy, Technogym SpA and Cosmed SrL.
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2425-9Authors
		A. Nicolucci, Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro, Chieti, ItalyS. Balducci, Department of Clinical and Molecular Medicine, “La Sapienza” University of Rome, Via di Grottaros...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582822</comments>
            <pubDate>Wed, 11 Jan 2012 06:55:41 +0100</pubDate>
            <guid isPermaLink="false">5582822</guid>        </item>
        <item>
            <title>Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting</title>
            <link>http://www.medworm.com/index.php?rid=5582824&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F07636665l881x772%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The score can be used to reliably identify those with undiagnosed IGR and type 2 diabetes in multiethnic populations. This
 is the first score developed taking into account HbA1c in the diagnosis of type 2 diabetes.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-8DOI 10.1007/s00125-011-2432-xAuthors
		L. J. Gray, Department of Health Sciences, University of Leicester, 22-28 Princess Road West, Leicester, LE1 6TP UKM. J. Davies, Department of Cardiovascular Sciences, University of Leicester, Leicester, UKS. Hiles, Department Diabetes Research, University Hospitals of Leicester, Leicester, UKN. A. Taub, Department of Health Sciences, University of Leicester, 22-28 Princess Road West, Leicester, LE1 6TP UKD. R. Webb, Department of Cardiovascular Sciences, ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582824</comments>
            <pubDate>Tue, 10 Jan 2012 06:41:48 +0100</pubDate>
            <guid isPermaLink="false">5582824</guid>        </item>
        <item>
            <title>The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways</title>
            <link>http://www.medworm.com/index.php?rid=5582825&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq863850361335117%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;The ghrelin gene-derived peptides and Ex-4 exert cytoprotective effects in islet MECs. The anti-apoptotic effects involve
 phosphoinositide 3-kinase (PI3K)/Akt, ERK1/2 and cAMP/PKA pathways. These peptides could therefore represent a potential tool
 to improve islet vascularisation and, indirectly, islet cell function.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-13DOI 10.1007/s00125-011-2423-yAuthors
		E. Favaro, Department of Internal Medicine, University of Turin, Corso Dogliotti 14, 10126 Turin, ItalyR. Granata, Department of Internal Medicine, Division of Endocrinology, Diabetology and Metabolism, University of Turin, Turin, ItalyI. Miceli, Department of Internal Medicine, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582825</comments>
            <pubDate>Mon, 09 Jan 2012 19:38:25 +0100</pubDate>
            <guid isPermaLink="false">5582825</guid>        </item>
        <item>
            <title>The association between prior infection with five serotypes of Coxsackievirus B and incident type 2 diabetes mellitus in the EPIC-Norfolk study</title>
            <link>http://www.medworm.com/index.php?rid=5582826&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F85m65h6q2vq43567%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;The presence of antibodies against any of five serotypes of Coxsackievirus B was not associated with incident type 2 diabetes.
 
 
 
	Content Type Journal ArticleCategory Short CommunicationPages 1-4DOI 10.1007/s00125-011-2443-7Authors
		E. Gkrania-Klotsas, Medical Research Council Epidemiology Unit, Addenbrooke’s Hospital, Box 285, Hills Road, Cambridge, CB2 0QQ UKC. Langenberg, Medical Research Council Epidemiology Unit, Addenbrooke’s Hospital, Box 285, Hills Road, Cambridge, CB2 0QQ UKS. Tauriainen, Department of Virology, University of Tampere, Tampere, FinlandS. J. Sharp, Medical Research Council Epidemiology Unit, Addenbrooke’s Hospital, Box 285, Hills Road, Cambridge, CB2 0QQ UKR. Luben, Department of Public Health and Primary Care, Instit...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582826</comments>
            <pubDate>Mon, 09 Jan 2012 19:38:24 +0100</pubDate>
            <guid isPermaLink="false">5582826</guid>        </item>
        <item>
            <title>Erratum to: Audit of acute Charcot’s disease in the UK: the CDUK study</title>
            <link>http://www.medworm.com/index.php?rid=5582828&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ffvt26g21m0374649%2F</link>
            <description>Content Type Journal ArticleCategory ErratumPages 1-1DOI 10.1007/s00125-011-2420-1Authors
		F. L. Game, Foot Ulcer Trials Unit, Department of Diabetes and Endocrinology, Nottingham University Hospitals Trust, City Hospital Campus, Hucknall Road, Nottingham, NG5 1PB UKR. Catlow, East Lancashire Healthcare Trust, Blackburn, UKG. R. Jones, East Lancashire Healthcare Trust, Blackburn, UKM. E. Edmonds, Kings College Hospital, London, UKE. B. Jude, Tameside General Hospital, Tameside, UKG. Rayman, Ipswich Hospital, Ipswich, UKW. J. Jeffcoate, Foot Ulcer Trials Unit, Department of Diabetes and Endocrinology, Nottingham University Hospitals Trust, City Hospital Campus, Hucknall Road, Nottingham, NG5 1PB UK
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582828</comments>
            <pubDate>Mon, 09 Jan 2012 19:38:23 +0100</pubDate>
            <guid isPermaLink="false">5582828</guid>        </item>
        <item>
            <title>Erratum to: Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase</title>
            <link>http://www.medworm.com/index.php?rid=5582827&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy113u4k51722xq58%2F</link>
            <description>Content Type Journal ArticleCategory ErratumPages 1-1DOI 10.1007/s00125-011-2406-zAuthors
		V. B. Matthews, Cellular and Molecular Metabolism Laboratory, Diabetes and Metabolism Division, Baker Heart Research Institute, PO Box 6492, St Kilda Road Central, Melbourne, VIC 8008, AustraliaM.-B. Åström, The Centre of Inflammation and Metabolism, Department of Infectious Diseases and CMRC, Rigshospitalet—Section 7641, Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, DenmarkM. H. S. Chan, Cellular and Molecular Metabolism Laboratory, Diabetes and Metabolism Division, Baker Heart Research Institute, PO Box 6492, St Kilda Road Central, Melbourne, VIC 8008, AustraliaC. R. Bruce, Cellular and Molecular Metabolism Laboratory, Diabetes and Metabolism Division,...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5582827</comments>
            <pubDate>Mon, 09 Jan 2012 19:38:23 +0100</pubDate>
            <guid isPermaLink="false">5582827</guid>        </item>
        <item>
            <title>Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database</title>
            <link>http://www.medworm.com/index.php?rid=5572577&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh721q55g62014150%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;There was no excess risk of cancer in type 2 diabetic patients on insulin glargine alone compared with those on human insulin
 alone. The overall risk of death or cancer in patients on insulin glargine was about half that of patients on human insulin,
 thereby excluding a competitive risk bias.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2429-5Authors
		P. Blin, Department of Pharmacology, Bat du Tondu, Case 40, Université de Bordeaux, 146 Rue Léo Saignat, 33076 Bordeaux, FranceR. Lassalle, Department of Pharmacology, Bat du Tondu, Case 40, Université de Bordeaux, 146 Rue Léo Saignat, 33076 Bordeaux, FranceC. Dureau-Pournin, Department of Pharmacology, Bat du Tondu, Case 40, Université de Bordeaux, 146 Rue...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572577</comments>
            <pubDate>Fri, 06 Jan 2012 06:43:40 +0100</pubDate>
            <guid isPermaLink="false">5572577</guid>        </item>
        <item>
            <title>Lentivirus shRNA Grb10 targeting the pancreas induces apoptosis and improved glucose tolerance due to decreased plasma glucagon levels</title>
            <link>http://www.medworm.com/index.php?rid=5572580&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F86560818232w172r%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;GRB10 is critically involved in alpha cell survival and, as a result, plays an important role in regulating basal glucagon
 secretion and glucose tolerance in adult mice.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2414-zAuthors
		B. Doiron, Diabetes Division, University of Texas Health Science Center at San Antonio, Mail Code 7886, 7703 Floyd Curl Drive, San Antonio, TX 78299, USAW. Hu, Diabetes Division, University of Texas Health Science Center at San Antonio, Mail Code 7886, 7703 Floyd Curl Drive, San Antonio, TX 78299, USAL. Norton, Diabetes Division, University of Texas Health Science Center at San Antonio, Mail Code 7886, 7703 Floyd Curl Drive, San Antonio, TX 78299, USAR. A. DeFronzo, Diabetes Division,...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572580</comments>
            <pubDate>Fri, 06 Jan 2012 06:43:39 +0100</pubDate>
            <guid isPermaLink="false">5572580</guid>        </item>
        <item>
            <title>Women develop diabetes at higher BMIs than men</title>
            <link>http://www.medworm.com/index.php?rid=5572579&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg148308770265350%2F</link>
            <description>Content Type Journal ArticleCategory LetterPages 1-2DOI 10.1007/s00125-011-2437-5Authors
		H. Sourij, Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, OX3 7LJ, UKR. R. Holman, Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, OX3 7LJ, UK
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia)</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572579</comments>
            <pubDate>Fri, 06 Jan 2012 06:43:39 +0100</pubDate>
            <guid isPermaLink="false">5572579</guid>        </item>
        <item>
            <title>Request for clarification from Ruiter et al regarding ‘Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’</title>
            <link>http://www.medworm.com/index.php?rid=5572578&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq33885194q475080%2F</link>
            <description>Content Type Journal ArticleCategory LetterPages 1-2DOI 10.1007/s00125-011-2436-6Authors
		B. Carstensen, Steno Diabetes Center, Niels Steensens Vej 2, 2829 Gentofte, Denmark
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia)</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572578</comments>
            <pubDate>Fri, 06 Jan 2012 06:43:39 +0100</pubDate>
            <guid isPermaLink="false">5572578</guid>        </item>
        <item>
            <title>The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5572581&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm108137h3684u365%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;We have developed clinical prediction models that calculate an individual’s probability of having MODY. This allows an improved
 and more rational approach to determine who should have molecular genetic testing.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-8DOI 10.1007/s00125-011-2418-8Authors
		B. M. Shields, Peninsula NIHR Clinical Research Facility, Peninsula Medical School, University of Exeter, Barrack Road, Exeter, EX2 5DW UKT. J. McDonald, Royal Devon and Exeter NHS Foundation Trust, Exeter, UKS. Ellard, Royal Devon and Exeter NHS Foundation Trust, Exeter, UKM. J. Campbell, School of Health and Related Research, University of Sheffield, Sheffield, UKC. Hyde, Peninsula Technology Assessment Group, Peninsula Medical School, Unive...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572581</comments>
            <pubDate>Wed, 04 Jan 2012 17:00:50 +0100</pubDate>
            <guid isPermaLink="false">5572581</guid>        </item>
        <item>
            <title>TGFβ modulates cell-to-cell communication in early epithelial-to-mesenchymal transition</title>
            <link>http://www.medworm.com/index.php?rid=5572582&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhr02g5021205n373%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;We provide compelling evidence that TGF-β1-induced EMT instigates a loss of E-cadherin, cell adhesion and ultimately of connexin-mediated
 cell communication in the proximal tubule under diabetic conditions; these changes occur ahead of overt signs of renal damage.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-13DOI 10.1007/s00125-011-2409-9Authors
		C. E. Hills, School of Life Sciences, University of Warwick, Coventry, CV4 7AL UKE. Siamantouras, School of Engineering, University of Warwick, Coventry, UKS. W. Smith, Department of Renal Immunobiology, Institute of Biomedical Research, University of Birmingham, Birmingham, UKP. Cockwell, Department of Renal Immunobiology, Institute of Biomedical Research, University of Birmingham, Birming...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572582</comments>
            <pubDate>Wed, 04 Jan 2012 07:01:30 +0100</pubDate>
            <guid isPermaLink="false">5572582</guid>        </item>
        <item>
            <title>Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle</title>
            <link>http://www.medworm.com/index.php?rid=5560743&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg2ut02p756625g11%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;AMPK phosphorylates and activates the insulin receptor, providing a direct link between AMPK and the insulin signalling pathway;
 this pathway promotes energy conservation and survival of muscle exposed to severe glucose deprivation.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-12DOI 10.1007/s00125-011-2407-yAuthors
		I. Chopra, Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, 1600 NW 10th Ave, RMSB 6038, Miami, FL 33136, USAH. F. Li, Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, 1600 NW 10th Ave, RMSB 6038, Miami, FL 33136, USAH. Wang, Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, 1600...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5560743</comments>
            <pubDate>Fri, 30 Dec 2011 07:08:20 +0100</pubDate>
            <guid isPermaLink="false">5560743</guid>        </item>
        <item>
            <title>Hepatic leptin signalling and subdiaphragmatic vagal efferents are not required for leptin-induced increases of plasma IGF binding protein-2 (IGFBP-2) in ob/ob mice</title>
            <link>http://www.medworm.com/index.php?rid=5552785&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp0r473t232860779%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Taken together, these data indicate that hepatic leptin signalling and subdiaphragmatic vagal inputs are not required for
 leptin upregulation of plasma IGFBP-2 nor blood glucose lowering in ob/ob mice.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2426-8Authors
		J. Levi, Department of Cellular and Physiological Sciences, Life Sciences Institute, 2350 Health Sciences Mall, University of British Columbia, Vancouver, BC, Canada V6T 1Z3F. K. Huynh, Department of Cellular and Physiological Sciences, Life Sciences Institute, 2350 Health Sciences Mall, University of British Columbia, Vancouver, BC, Canada V6T 1Z3H. C. Denroche, Department of Cellular and Physiological Sciences, Life Sciences Institute, 2350 Health Sci...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552785</comments>
            <pubDate>Tue, 27 Dec 2011 17:04:39 +0100</pubDate>
            <guid isPermaLink="false">5552785</guid>        </item>
        <item>
            <title>The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial</title>
            <link>http://www.medworm.com/index.php?rid=5552786&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1682p1063005u388%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Oral treatment of 4&amp;nbsp;weeks duration with the dual endothelin receptor antagonist, bosentan, improves peripheral endothelial
 function in patients with type 2 diabetes and microalbuminuria.
 
 
 
 
 Trial Registration:&amp;nbsp;&amp;nbsp;ClinicalTrial.gov NCT01357109; Karolinska Clinical Trial Registration Identifier CT20090017 (see www.kctr.se)
 
 
 
 
 Funding:&amp;nbsp;&amp;nbsp;Research Council of Sweden, Swedish Heart and Lung Foundation, Novo Nordisk Foundation, Karolinska Institutet/Stockholm County
 Council Strategic Cardiovascular Programme, Gustav V and Queen Victoria Foundation, the Family Erling Persson Foundation,
 Actelion Pharmaceuticals and Actelion Research Award.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-8DOI 10.1007/s00125-011-...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552786</comments>
            <pubDate>Mon, 26 Dec 2011 16:46:56 +0100</pubDate>
            <guid isPermaLink="false">5552786</guid>        </item>
        <item>
            <title>Novel versus traditional risk markers for diabetic retinopathy</title>
            <link>http://www.medworm.com/index.php?rid=5544847&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpw583823353161hg%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;ApoAI and retinal arteriolar tortuosity made considerable contributions to DR risk, independently of traditional risk markers.
 Findings from this study suggest that serum ApoAI and retinal arteriolar tortuosity may be novel and independent risk markers
 of DR.
 
 
 
 
	Content Type Journal ArticleCategory Short CommunicationPages 1-5DOI 10.1007/s00125-011-2424-xAuthors
		M. B. Sasongko, Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, 32 Gisborne Street, Melbourne, VIC 3002, AustraliaT. Y. Wong, Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, 32 Gisborne Street, Melbourne, VIC 3002, AustraliaT. T. Nguyen, Centre for Eye Research Australia, Royal Victoria...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544847</comments>
            <pubDate>Sat, 24 Dec 2011 06:42:02 +0100</pubDate>
            <guid isPermaLink="false">5544847</guid>        </item>
        <item>
            <title>The course of depressive symptoms in primary care patients with type 2 diabetes: results from the Diabetes, Depression, Type D Personality Zuidoost-Brabant (DiaDDZoB) Study</title>
            <link>http://www.medworm.com/index.php?rid=5544846&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F02568147141n5791%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Depression is common in primary care patients with type 2 diabetes, with one in seven patients reporting incident depression
 during a 2.5&amp;nbsp;year period. Once present, depression often becomes a chronic/recurrent condition in this group. In order to
 identify patients who are vulnerable to depression, clinicians can use questionnaire data and/or information about the history
 of depression.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-9DOI 10.1007/s00125-011-2411-2Authors
		G. Nefs, Center of Research on Psychology in Somatic diseases (CoRPS), Department of Medical Psychology and Neuropsychology, Tilburg University, PO Box 90153, 5000 LE Tilburg, the NetherlandsF. Pouwer, Center of Research on Psychology in Somatic diseases (CoRPS), ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544846</comments>
            <pubDate>Sat, 24 Dec 2011 06:42:02 +0100</pubDate>
            <guid isPermaLink="false">5544846</guid>        </item>
        <item>
            <title>Disruption of the association of integrin-associated protein (IAP) with tyrosine phosphatase non-receptor type substrate-1 (SHPS)-1 inhibits pathophysiological changes in retinal endothelial function in a rat model of diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5544849&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F01n310v77tu6g706%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Our results demonstrate that the increased association of IAP with SHPS-1 contributes to the pathophysiological changes in
 the endothelium that are induced by hyperglycaemia and hypoxia.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2416-xAuthors
		L. A. Maile, Departments of Medicine and Ophthalmology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAK. Gollahon, Departments of Medicine and Ophthalmology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAC. Wai, Departments of Medicine and Ophthalmology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAG. Byfield, Departments of Medicine and Ophthalmology,...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544849</comments>
            <pubDate>Fri, 23 Dec 2011 06:49:32 +0100</pubDate>
            <guid isPermaLink="false">5544849</guid>        </item>
        <item>
            <title>Insulin resistance and arterial stiffness in healthy adolescents and young adults</title>
            <link>http://www.medworm.com/index.php?rid=5544848&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8802321k63841438%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Although IR is associated with increased arterial stiffness, traditional cardiovascular risk factors, especially obesity and
 BP, are the major determinants of arterial stiffness in healthy young people.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-7DOI 10.1007/s00125-011-2412-1Authors
		E. M. Urbina, Department of Pediatrics, Preventive Cardiology, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati, 3333 Burnet Avenue, MLC-7002, Cincinnati, OH 45229, USAZ. Gao, Department of Pediatrics, Preventive Cardiology, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati, 3333 Burnet Avenue, MLC-7002, Cincinnati, OH 45229, USAP. R. Khoury, Department of Pediatrics, Preventive Cardiology, ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544848</comments>
            <pubDate>Fri, 23 Dec 2011 06:49:32 +0100</pubDate>
            <guid isPermaLink="false">5544848</guid>        </item>
        <item>
            <title>Small fibre dysfunction, microvascular complications and glycaemic control in type 1 diabetes: a case–control study</title>
            <link>http://www.medworm.com/index.php?rid=5544850&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7262220810u65u2v%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;We have shown that glycaemic burden and the presence of microvascular complications are associated with small fibre dysfunction
 in type 1 diabetes.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-6DOI 10.1007/s00125-011-2417-9Authors
		P. R. J. Vas, The Diabetes Research Centre, Ipswich Hospital NHS Trust, Heath Road, Ipswich, Suffolk IP4 5PD, UKA. Q. Green, The Diabetes Research Centre, Ipswich Hospital NHS Trust, Heath Road, Ipswich, Suffolk IP4 5PD, UKG. Rayman, The Diabetes Research Centre, Ipswich Hospital NHS Trust, Heath Road, Ipswich, Suffolk IP4 5PD, UK
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia)</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544850</comments>
            <pubDate>Fri, 23 Dec 2011 06:49:30 +0100</pubDate>
            <guid isPermaLink="false">5544850</guid>        </item>
        <item>
            <title>What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review</title>
            <link>http://www.medworm.com/index.php?rid=5544851&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3530lp221w512x29%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Physical activity improves well-being and reduces the risk of heart disease, cancer and type 2 diabetes mellitus in the general
 population. In individuals with established type 2 diabetes, physical activity improves glucose and lipid levels, reduces
 weight and improves insulin resistance. In type 1 diabetes mellitus, however, the benefits of physical activity are less clear.
 There is poor evidence for a beneficial effect of physical activity on glycaemic control and microvascular complications,
 and significant risk of harm through hypoglycaemia. Here we review the literature relating to physical activity and health
 in type 1 diabetes. We examine its effect on a number of outcomes, including glycaemic control, lipids, blood pressure, diabetic
 complications, well-be...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544851</comments>
            <pubDate>Thu, 22 Dec 2011 06:44:45 +0100</pubDate>
            <guid isPermaLink="false">5544851</guid>        </item>
        <item>
            <title>Multivesicular exocytosis in rat pancreatic beta cells</title>
            <link>http://www.medworm.com/index.php?rid=5544852&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5h73543445461423%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Although contributing marginally to glucose-induced insulin secretion, compound exocytosis becomes quantitatively significant
 under conditions associated with global elevation of cytoplasmic calcium. These findings suggest that compound exocytosis
 is a major contributor to the augmentation of glucose-induced insulin secretion by muscarinic receptor activation.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-12DOI 10.1007/s00125-011-2400-5Authors
		M. B. Hoppa, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, OX3 7LJ UKE. Jones, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, OX3 7LJ UKJ. Karanauskaite, Oxford Centre for Diabetes, Endocrinology and Metabolism, ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544852</comments>
            <pubDate>Wed, 21 Dec 2011 20:06:01 +0100</pubDate>
            <guid isPermaLink="false">5544852</guid>        </item>
        <item>
            <title>Reno-protective effects of renin–angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=5544853&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv83047k45k62u103%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Our review suggests a consistent reno-protective effect of ACEI/ARB over other antihypertensive drugs, mainly CCBs, and placebo
 in type 2 diabetes. The lack of any differences in BP decrease between ACEI/ARB and active comparators suggest this benefit
 is not due simply to the antihypertensive effect.
 
 
 
 
	Content Type Journal ArticleCategory Meta-analysisPages 1-13DOI 10.1007/s00125-011-2398-8Authors
		P. Vejakama, Section for Clinical Epidemiology and Biostatistics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Rama 6 Road, Rachatevi, Bangkok, 10400 ThailandA. Thakkinstian, Section for Clinical Epidemiology and Biostatistics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Rama 6 Road, Rachatevi, Bangkok, 10400 Th...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544853</comments>
            <pubDate>Wed, 21 Dec 2011 20:06:00 +0100</pubDate>
            <guid isPermaLink="false">5544853</guid>        </item>
        <item>
            <title>Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds</title>
            <link>http://www.medworm.com/index.php?rid=5544854&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe038w1t4811323w2%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;In patients with type 2 diabetes, HbA1c levels were associated with lower risks of macrovascular events and death down to a threshold of 7.0% and microvascular events
 down to a threshold of 6.5%. There was no evidence of lower risks below these levels but neither was there clear evidence
 of harm.
 
 
 
 
 Trial Registration:&amp;nbsp;&amp;nbsp;ClinicalTrial.gov NCT00145925
 
 
 
 Funding:&amp;nbsp;&amp;nbsp;Servier and the National Health and Medical Research Council of Australia (project grant ID 211086 and programme grant IDs
 358395 and 571281)
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-8DOI 10.1007/s00125-011-2404-1Authors
		S. Zoungas, The George Institute for Global Health, PO Box M201, Missenden Road, Camperdown, NSW 2050 Sydney, NSW, Austra...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544854</comments>
            <pubDate>Wed, 21 Dec 2011 19:46:30 +0100</pubDate>
            <guid isPermaLink="false">5544854</guid>        </item>
        <item>
            <title>Socioeconomic factors, rather than diabetes mellitus per se, contribute to an excessive use of antidepressants among young adults with childhood onset type 1 diabetes mellitus: a register-based study</title>
            <link>http://www.medworm.com/index.php?rid=5515801&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff7532711h2114135%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;The risk factor patterns for AD use are similar among type 1 diabetic patients and controls, and socioeconomic risk factors,
 rather than the diabetes per se, contribute to the increased risk of AD use in young adults with type 1 diabetes.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-8DOI 10.1007/s00125-011-2405-0Authors
		T. Lind, Department of Clinical Sciences, Pediatrics, Umeå University, 901 87 Umeå, SwedenI. Waernbaum, Department of Statistics, Umeå University, Umeå, SwedenY. Berhan, Department of Clinical Sciences, Pediatrics, Umeå University, 901 87 Umeå, SwedenG. Dahlquist, Department of Clinical Sciences, Pediatrics, Umeå University, 901 87 Umeå, Sweden
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-18...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515801</comments>
            <pubDate>Fri, 16 Dec 2011 17:29:02 +0100</pubDate>
            <guid isPermaLink="false">5515801</guid>        </item>
        <item>
            <title>The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells</title>
            <link>http://www.medworm.com/index.php?rid=5515802&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6185q118v14244r2%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Overall, our findings show that the PPARβ/δ activator GW501516 prevents IL-6-induced STAT3 activation by inhibiting ERK1/2
 phosphorylation and preventing the reduction in phospho-AMPK levels. These effects of GW501516 may contribute to the prevention
 of cytokine-induced insulin resistance in hepatic cells.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-9DOI 10.1007/s00125-011-2401-4Authors
		L. Serrano-Marco, Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Faculty of Pharmacy, University of Barcelona, Institut de Biomedicina de la UB (IBUB), Diagonal 643, E-08028 Barcelona, SpainE. Barroso, Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Faculty of Pharmacy, University of Barcelona, In...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515802</comments>
            <pubDate>Fri, 16 Dec 2011 17:28:59 +0100</pubDate>
            <guid isPermaLink="false">5515802</guid>        </item>
        <item>
            <title>Postprandial whole-body glycolysis is similar in insulin-resistant and insulin-sensitive non-diabetic humans</title>
            <link>http://www.medworm.com/index.php?rid=5515803&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh4819n3xv281q4h2%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Postprandial hyperinsulinaemia and modest hyperglycaemia overcome insulin resistance by enhancing tissue glucose uptake and
 intracellular glucose utilisation.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-6DOI 10.1007/s00125-011-2413-0Authors
		J. E. Galgani, Department of Nutrition, Faculty of Medicine, University of Chile, Independencia 1027, Clasificador 7, Santiago, ChileE. Ravussin, Pennington Biomedical Research Center, Baton Rouge, LA, USA
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia)</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515803</comments>
            <pubDate>Thu, 15 Dec 2011 16:49:15 +0100</pubDate>
            <guid isPermaLink="false">5515803</guid>        </item>
        <item>
            <title>Retraction Note: A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells</title>
            <link>http://www.medworm.com/index.php?rid=5515804&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc21672360h53t116%2F</link>
            <description>Content Type Journal ArticleCategory Retraction NotePages 1-1DOI 10.1007/s00125-011-2394-zAuthors
		Y. Hattori, Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, JapanT. Jojima, Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, JapanA. Tomizawa, Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, JapanH. Satoh, Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, JapanS. Hattori, Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, JapanK. Kasai, Department of Endocrinology and Metabolism, Dokkyo University School of Med...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515804</comments>
            <pubDate>Wed, 14 Dec 2011 16:41:26 +0100</pubDate>
            <guid isPermaLink="false">5515804</guid>        </item>
        <item>
            <title>Erratum to: Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5515806&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft871w21451258x20%2F</link>
            <description>Content Type Journal ArticleCategory ErratumPages 1-1DOI 10.1007/s00125-011-2389-9Authors
		M. Igoillo-Esteve, Laboratory of Experimental Medicine, Université Libre de Bruxelles, CP-618, Route de Lennik 808, 1070 Brussels, BelgiumL. Marselli, Department of Endocrinology and Metabolism, Metabolic Unit–University of Pisa, Pisa, ItalyD. A. Cunha, Laboratory of Experimental Medicine, Université Libre de Bruxelles, CP-618, Route de Lennik 808, 1070 Brussels, BelgiumL. Ladrière, Laboratory of Experimental Medicine, Université Libre de Bruxelles, CP-618, Route de Lennik 808, 1070 Brussels, BelgiumF. Ortis, Laboratory of Experimental Medicine, Université Libre de Bruxelles, CP-618, Route de Lennik 808, 1070 Brussels, BelgiumF. A. Grieco, Department of Internal Medicine, Endocrine and Meta...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515806</comments>
            <pubDate>Wed, 14 Dec 2011 16:41:25 +0100</pubDate>
            <guid isPermaLink="false">5515806</guid>        </item>
        <item>
            <title>Age at menarche is associated with prediabetes and diabetes in women (aged 32–81 years) from the general population: the KORA F4 Study</title>
            <link>http://www.medworm.com/index.php?rid=5515805&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb527xmhm84128151%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Age at menarche seems to be inversely associated with prediabetes and diabetes independent of confounding factors including
 current BMI. Women at risk for diabetes might be identified by a history of young age at menarche.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-8DOI 10.1007/s00125-011-2410-3Authors
		D. Stöckl, Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstr. 1, D-85764 Neuherberg, GermanyA. Döring, Institute of Epidemiology I, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, GermanyA. Peters, Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstäd...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515805</comments>
            <pubDate>Wed, 14 Dec 2011 16:41:25 +0100</pubDate>
            <guid isPermaLink="false">5515805</guid>        </item>
        <item>
            <title>Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5515807&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2112631p5151h123%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Higher sedentary time is associated with a poorer metabolic profile in people with type 2 diabetes.
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2408-xAuthors
		A. R. Cooper, Centre for Exercise, Nutrition and Health Sciences, School for Policy Studies, University of Bristol, 8 Priory Road, Bristol, BS8 1TZ UKS. Sebire, Centre for Exercise, Nutrition and Health Sciences, School for Policy Studies, University of Bristol, 8 Priory Road, Bristol, BS8 1TZ UKA. A. Montgomery, School of Social and Community Medicine, University of Bristol, Bristol, UKT. J. Peters, School of Social and Community Medicine, University of Bristol, Bristol, UKD. J. Sharp, School of Social and Community Medicine, University of Bristol, Bristo...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515807</comments>
            <pubDate>Wed, 14 Dec 2011 06:56:57 +0100</pubDate>
            <guid isPermaLink="false">5515807</guid>        </item>
        <item>
            <title>Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets</title>
            <link>http://www.medworm.com/index.php?rid=5515809&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F733354185xl5u282%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Our results suggest that human islets have a distinctive distribution and function of key regulators of the glucose-stimulated
 insulin secretion pathway, emphasising the urgent need to understand the processes that regulate human islet beta cell function.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-12DOI 10.1007/s00125-011-2369-0Authors
		C. Dai, Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University, 7435 MRBIV, Nashville, TN 37232, USAM. Brissova, Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University, 7435 MRBIV, Nashville, TN 37232, USAY. Hang, Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, T...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515809</comments>
            <pubDate>Tue, 13 Dec 2011 17:05:12 +0100</pubDate>
            <guid isPermaLink="false">5515809</guid>        </item>
        <item>
            <title>Muscle microvascular recruitment predicts insulin sensitivity in middle-aged patients with type 1 diabetes mellitus</title>
            <link>http://www.medworm.com/index.php?rid=5515808&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpj75h53718426278%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;We conclude that moderate overnight hyperinsulinaemia recruited microvasculature in the more sensitive participants, while
 higher levels of plasma insulin were needed for more insulin resistant participants. This suggests that microvascular responsiveness
 to insulin is one determinant of metabolic insulin sensitivity in type 1 diabetes.
 
 
 
 
 Trial registration:&amp;nbsp;&amp;nbsp;ClinicalTrials.gov NCT00943787
 
 
 
 Funding:&amp;nbsp;&amp;nbsp;This study is supported by the NIH/NIDDKRO1 DK 51562 grant and the University of Virginia General Clinical Research Center
 M01 RR 000847 grant.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-8DOI 10.1007/s00125-011-2402-3Authors
		A. Chan, Center for Diabetes Technology, University of Virginia, P.O. 400 888...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515808</comments>
            <pubDate>Tue, 13 Dec 2011 17:05:12 +0100</pubDate>
            <guid isPermaLink="false">5515808</guid>        </item>
        <item>
            <title>B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men</title>
            <link>http://www.medworm.com/index.php?rid=5515812&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F57680023x347x4n5%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Intravenous administration of BNP increases glucose initial distribution volume and lowers plasma glucose concentrations following
 a glucose load, without affecting beta cell function or insulin sensitivity. These data support the theory that BNP has no
 diabetogenic properties, but improves metabolic status in men, and suggest new questions regarding BNP-induced differences
 in glucose availability and signalling in various organs/tissues.
 
 
 
 
 Trial registration:&amp;nbsp;&amp;nbsp; ClinicalTrials.gov: NCT01324739
 
 
 
 Funding:&amp;nbsp;&amp;nbsp; The study was funded by Jubilée Fonds of the Austrian National Bank (OeNB-Fonds).
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-6DOI 10.1007/s00125-011-2392-1Authors
		B. B. Heinisch, Department of Cli...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515812</comments>
            <pubDate>Tue, 13 Dec 2011 06:55:49 +0100</pubDate>
            <guid isPermaLink="false">5515812</guid>        </item>
        <item>
            <title>Involvement of the RNA-binding protein ARE/poly(U)-binding factor 1 (AUF1) in the cytotoxic effects of proinflammatory cytokines on pancreatic beta cells</title>
            <link>http://www.medworm.com/index.php?rid=5515811&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd8627w120q5703x0%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Our findings point to a contribution of AUF1 to the deleterious effects of cytokines on beta cell functions and suggest a
 role for this RNA-binding protein in the early phases of type 1 diabetes.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2399-7Authors
		E. Roggli, Department of Cell Biology and Morphology, Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 9, CH-1005 Lausanne, SwitzerlandS. Gattesco, Department of Cell Biology and Morphology, Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 9, CH-1005 Lausanne, SwitzerlandA. Pautz, Department of Pharmacology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, GermanyR. Regazzi, Department of...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515811</comments>
            <pubDate>Tue, 13 Dec 2011 06:55:49 +0100</pubDate>
            <guid isPermaLink="false">5515811</guid>        </item>
        <item>
            <title>Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)–nuclear factor-κB (NFκB) activation in rat muscle, in the absence of mitochondrial dysfunction</title>
            <link>http://www.medworm.com/index.php?rid=5515810&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd0226p60v8h46877%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Acute muscle insulin effects include enhanced ROS generation through xanthine oxidase. Additional NEFA elevation enhances
 mitochondrial ROS generation, activates IκB–NFκB and reduces insulin signalling. These alterations are not associated with
 acute reductions in mitochondrial enzyme activity and ATP production, and are reversed by antioxidant infusion. Thus, NEFA
 acutely cause systemic and muscle insulin resistance by enhancing muscle oxidative stress through mitochondrial ROS generation
 and IκB–NFκB activation.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2396-xAuthors
		R. Barazzoni, Clinica Medica, Department of Medical, Surgical and Health Sciences, University of Trieste, Ospedale Cattinara, St...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515810</comments>
            <pubDate>Tue, 13 Dec 2011 06:55:49 +0100</pubDate>
            <guid isPermaLink="false">5515810</guid>        </item>
        <item>
            <title>Increased metabolic rate and insulin sensitivity in male mice lacking the carcino-embryonic antigen-related cell adhesion molecule 2</title>
            <link>http://www.medworm.com/index.php?rid=5495206&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy2q65361x1783h92%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;These studies identified a novel role for CEACAM2 in the regulation of metabolic rate and insulin sensitivity via effects
 on brown adipogenesis, sympathetic nervous outflow to brown adipose tissue, spontaneous activity and energy expenditure in
 skeletal muscle.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2388-xAuthors
		P. R. Patel, Center for Diabetes and Endocrine Research, College of Medicine and Life Sciences, University of Toledo, Health Science Campus, 3000 Arlington Avenue, Mail Stop 1009, Toledo, OH 43614, USAS. K. Ramakrishnan, Center for Diabetes and Endocrine Research, College of Medicine and Life Sciences, University of Toledo, Health Science Campus, 3000 Arlington Avenue, Mail Stop 1009, Toledo, ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5495206</comments>
            <pubDate>Sat, 10 Dec 2011 16:56:01 +0100</pubDate>
            <guid isPermaLink="false">5495206</guid>        </item>
        <item>
            <title>The importance of beta cell characterisation: generating human beta cells by differentiating human embryonic stem cells</title>
            <link>http://www.medworm.com/index.php?rid=5487648&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr55542m281704m20%2F</link>
            <description>Content Type Journal ArticleCategory CommentaryPages 1-3DOI 10.1007/s00125-011-2397-9Authors
		G. S. Korbutt, Department of Surgery, Alberta Diabetes Institute, Edmonton, AB, CanadaT. Y. Yeung, Department of Surgery, Alberta Diabetes Institute, Edmonton, AB, CanadaC. E. Ellis, Department of Surgery, Alberta Diabetes Institute, Edmonton, AB, Canada
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia)</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5487648</comments>
            <pubDate>Tue, 06 Dec 2011 17:04:13 +0100</pubDate>
            <guid isPermaLink="false">5487648</guid>        </item>
        <item>
            <title>Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology</title>
            <link>http://www.medworm.com/index.php?rid=5487649&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4r175454148r0643%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Detoxification of MG reduces AGE adduct accumulation, which, in turn, can prevent formation of key retinal neuroglial and
 vascular lesions as diabetes progresses. MG-derived AGEs play an important role in diabetic retinopathy.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2393-0Authors
		A. K. Berner, Centre for Vision and Vascular Science, Queen’s University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA Northern Ireland, UKO. Brouwers, Department of Internal Medicine, Universiteit Maastricht, Maastricht, the NetherlandsR. Pringle, Centre for Vision and Vascular Science, Queen’s University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA Northern Ireland, UKI. Klaassen, Department of Ophthalmology, ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5487649</comments>
            <pubDate>Mon, 05 Dec 2011 17:40:54 +0100</pubDate>
            <guid isPermaLink="false">5487649</guid>        </item>
        <item>
            <title>Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study</title>
            <link>http://www.medworm.com/index.php?rid=5477052&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft64h32g223741q8k%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Colesevelam, a non-absorbed bile acid sequestrant, increased circulating incretins and improved tissue glucose metabolism
 in both the fasting and postprandial states in a manner different from other approved oral agents.
 
 
 
 
 Trial registration:&amp;nbsp;&amp;nbsp;ClinicalTrials.gov NCT00596427
 
 
 
 Funding:&amp;nbsp;&amp;nbsp;The study was funded by Daiichi Sankyo.
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2382-3Authors
		C. Beysen, Kinemed, Inc., 5980 Horton Street Suite 470, Emeryville, CA 94608, USAE. J. Murphy, Division of Endocrinology and Metabolism, University of California, San Francisco, CA, USAK. Deines, Kinemed, Inc., 5980 Horton Street Suite 470, Emeryville, CA 94608, USAM. Chan, Kinemed, Inc., 5980 Horton ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477052</comments>
            <pubDate>Fri, 02 Dec 2011 06:47:42 +0100</pubDate>
            <guid isPermaLink="false">5477052</guid>        </item>
        <item>
            <title>Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility—Reykjavik Study (AGES-R)</title>
            <link>http://www.medworm.com/index.php?rid=5477053&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj86881p5gt007182%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Over three-quarters (78%) of retinopathy cases were found in persons without diabetes and a strong association between microalbuminuria
 and non-diabetic retinopathy was found. These results may have implications for patient management of the aged.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2395-yAuthors
		E. Gunnlaugsdottir, University Eye Department, Landspitalinn, 101 Reykjavik, IcelandS. Halldorsdottir, Icelandic Heart Association, Kopavogur, IcelandR. Klein, Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USAG. Eiriksdottir, Icelandic Heart Association, Kopavogur, IcelandB. E. Klein, Department of Ophthalmology and Visual Sciences...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477053</comments>
            <pubDate>Fri, 02 Dec 2011 06:47:41 +0100</pubDate>
            <guid isPermaLink="false">5477053</guid>        </item>
        <item>
            <title>Pathogenic role of mast cells in the development of diabetic nephropathy: a study of patients at different stages of the disease</title>
            <link>http://www.medworm.com/index.php?rid=5477054&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F12558x432247g522%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;This study suggests that mast cells are involved in development of diabetic nephropathy. Through release of bioactive substances,
 such as tryptase, chymase, TGF-β1, renin and TNF-α, into the tubular interstitium by degranulation, mast cells could promote
 renal inflammation and fibrosis, and thus contribute to diabetic nephropathy.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2391-2Authors
		J. M. Zheng, Research Institute of Nephrology, Jingling Hospital, Nanjing University School of Medicine, 305 East Zhongshan Road, Nanjing, 210002 People’s Republic of ChinaG. H. Yao, Research Institute of Nephrology, Jingling Hospital, Nanjing University School of Medicine, 305 East Zhongshan Road, Nanjing, 210002 Peopl...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477054</comments>
            <pubDate>Thu, 01 Dec 2011 06:59:04 +0100</pubDate>
            <guid isPermaLink="false">5477054</guid>        </item>
        <item>
            <title>Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data</title>
            <link>http://www.medworm.com/index.php?rid=5469472&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe1124783527g041h%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;These findings do not provide evidence of either beneficial or adverse effects of glucose-lowering agents on cancer risk and
 are consistent with changes in diabetes treatment in the few months prior to the diagnosis of cancer.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-12DOI 10.1007/s00125-011-2390-3Authors
		T. P. van Staa, General Practice Research Database, Medicines and Healthcare products Regulatory Agency, Buckingham Palace Road, London, SW1W 9SZ UKD. Patel, General Practice Research Database, Medicines and Healthcare products Regulatory Agency, Buckingham Palace Road, London, SW1W 9SZ UKA. M. Gallagher, General Practice Research Database, Medicines and Healthcare products Regulatory Agency, Buckingham Palace Road, London, SW1W 9SZ UKM. L. de...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5469472</comments>
            <pubDate>Wed, 30 Nov 2011 09:21:54 +0100</pubDate>
            <guid isPermaLink="false">5469472</guid>        </item>
        <item>
            <title>Causes of death among diabetic patients in Denmark</title>
            <link>http://www.medworm.com/index.php?rid=5469473&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7712j8454n51q324%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Age-specific mortality is higher among people with diabetes, and rate ratios vary with age, sex, calendar period and cause
 of death. The distribution of causes of death was similar for persons with and without diabetes.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-9DOI 10.1007/s00125-011-2383-2Authors
		M. B. Hansen, Steno Diabetes Center A/S, Niels Steensens Vej 2, DK-2820 Gentofte, DenmarkM. L. Jensen, Steno Diabetes Center A/S, Niels Steensens Vej 2, DK-2820 Gentofte, DenmarkB. Carstensen, Steno Diabetes Center A/S, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia)</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5469473</comments>
            <pubDate>Wed, 30 Nov 2011 04:56:38 +0100</pubDate>
            <guid isPermaLink="false">5469473</guid>        </item>
        <item>
            <title>Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome?</title>
            <link>http://www.medworm.com/index.php?rid=5469475&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft60q16484kqg551m%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;We showed that dSLs are significantly elevated in patients with type 2 diabetes mellitus and non-diabetic metabolic syndrome
 compared with healthy controls. They may, therefore, be useful novel biomarkers to improve risk prediction and therapy monitoring
 in these patients.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2384-1Authors
		A. Othman, Institute for Clinical Chemistry, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, SwitzerlandM. F. Rütti, Institute for Clinical Chemistry, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, SwitzerlandD. Ernst, Institute for Clinical Chemistry, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, SwitzerlandC. H. Saely, Vorarlberg Institute for...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5469475</comments>
            <pubDate>Tue, 29 Nov 2011 22:23:16 +0100</pubDate>
            <guid isPermaLink="false">5469475</guid>        </item>
        <item>
            <title>Innate immunity, insulin resistance and type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5469474&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb35p4341hl735064%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In this edition of ‘Then and now’ the initial studies by J.C. Pickup and colleagues supporting the hypothesis that type 2
 diabetes is caused by activated innate immunity, published in Diabetologia in 1997 (40:1286–1292), are discussed. These initial findings led to research that has uncovered links between insulin resistance,
 obesity, circulating immune markers, immunogenetic susceptibility, macrophage function and chronic infection. Genetic variations
 leading to the altered production or function of circulating innate immune proteins, cellular pattern recognition receptors
 and inflammatory cytokines are linked to obesity, insulin resistance and type 2 diabetes. Components of the innate immune
 system in the muscle, bone, liver and adipose tissue, as well as m...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5469474</comments>
            <pubDate>Tue, 29 Nov 2011 22:23:16 +0100</pubDate>
            <guid isPermaLink="false">5469474</guid>        </item>
        <item>
            <title>Both resistance- and endurance-type exercise reduce the prevalence of hyperglycaemia in individuals with impaired glucose tolerance and in insulin-treated and non-insulin-treated type 2 diabetic patients</title>
            <link>http://www.medworm.com/index.php?rid=5469476&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa451544286267820%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;A single session of resistance- or endurance-type exercise substantially reduces the prevalence of hyperglycaemia during the
 subsequent 24&amp;nbsp;h period in individuals with IGT, and in insulin-treated and non-insulin-treated type 2 diabetic patients. Both
 resistance- and endurance-type exercise can be integrated in exercise intervention programmes designed to improve glycaemic
 control.
 
 
 
 
 Trial registration:&amp;nbsp;&amp;nbsp;Clinicaltrials.gov NCT00945165
 
 
 
 Funding:&amp;nbsp;&amp;nbsp;The Netherlands Organization for Health Research and Development (ZonMw, the Netherlands).
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2380-5Authors
		J.-W. van Dijk, Department of Human Movement Sciences, NUTRIM School for Nutritio...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5469476</comments>
            <pubDate>Tue, 29 Nov 2011 22:23:15 +0100</pubDate>
            <guid isPermaLink="false">5469476</guid>        </item>
        <item>
            <title>T cell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice</title>
            <link>http://www.medworm.com/index.php?rid=5458410&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl32n77128860201g%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;These results indicate that TCPTP deficiency in muscle has no effect on insulin signalling and glucose homeostasis, and does
 not prevent high-fat diet-induced insulin resistance. Thus, despite their high degree of sequence identity, PTP1B and TCPTP
 contribute differentially to insulin receptor regulation in muscle. Our results are consistent with the notion that these
 two highly related PTPs make distinct contributions to insulin receptor regulation in different tissues.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2386-zAuthors
		K. Loh, Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC 3800, AustraliaT. L. Merry, Department of Biochemistry and Molecular Biology, Monash Univ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5458410</comments>
            <pubDate>Mon, 28 Nov 2011 16:59:49 +0100</pubDate>
            <guid isPermaLink="false">5458410</guid>        </item>
        <item>
            <title>Cancer occurrence in Danish diabetic patients: duration and insulin effects</title>
            <link>http://www.medworm.com/index.php?rid=5458411&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr76541174511q011%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The observed duration effects suggest that both increased surveillance for cancer in the first years after diagnosis of diabetes,
 and reverse causation, where undiagnosed cancers increase the likelihood of diabetes diagnosis, play a role. For longer durations,
 a combination of common causes for diabetes and cancer, as well as the effects of diabetes and insulin exposure per se, may
 play a role in the association between diabetes and some cancers.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2381-4Authors
		B. Carstensen, Steno Diabetes Center, Niels Steensens Vej 2, 2829 Gentofte, DenmarkD. R. Witte, Department of Biostatistics, University of Copenhagen, Copenhagen, DenmarkS. Friis, Institute of Cancer Epidemiology, Danish ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5458411</comments>
            <pubDate>Sat, 26 Nov 2011 16:48:35 +0100</pubDate>
            <guid isPermaLink="false">5458411</guid>        </item>
        <item>
            <title>INSGFP/w human embryonic stem cells facilitate isolation of in vitro derived insulin-producing cells</title>
            <link>http://www.medworm.com/index.php?rid=5458412&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq580612421090679%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;
 INS
 
 GFP/w
 hESCs are a valuable tool for investigating the nature of early INS+ progenitors in beta cell ontogeny and will facilitate the development of novel protocols for generating INS+ cells from differentiating hESCs.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-13DOI 10.1007/s00125-011-2379-yAuthors
		S. J. Micallef, Monash Immunology and Stem Cell Laboratories (MISCL), Level 3, Building 75, STRIP1, West Ring Road, Monash University, Clayton, Victoria 3800, AustraliaX. Li, Monash Immunology and Stem Cell Laboratories (MISCL), Level 3, Building 75, STRIP1, West Ring Road, Monash University, Clayton, Victoria 3800, AustraliaJ. V. Schiesser, Monash Immunology and Stem Cell Laboratories (MISCL), Level 3, Building 75, STRIP1, West...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5458412</comments>
            <pubDate>Sat, 26 Nov 2011 06:42:04 +0100</pubDate>
            <guid isPermaLink="false">5458412</guid>        </item>
        <item>
            <title>Impact of circulating vaspin levels on metabolic variables in elderly twins</title>
            <link>http://www.medworm.com/index.php?rid=5449948&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk32k48u751u31023%2F</link>
            <description>Content Type Journal ArticleCategory Research LetterPages 1-3DOI 10.1007/s00125-011-2385-0Authors
		K. Hida, Steno Diabetes Center, Niels Steensens Vej1, 2820 Gentofte, DenmarkP. Poulsen, Novo Nordisk A/S, Soeborg, DenmarkS. Teshigawara, Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, JapanE. Nilsson, Steno Diabetes Center, Niels Steensens Vej1, 2820 Gentofte, DenmarkM. Friedrichsen, Steno Diabetes Center, Niels Steensens Vej1, 2820 Gentofte, DenmarkR. Ribel-Madsen, Steno Diabetes Center, Niels Steensens Vej1, 2820 Gentofte, DenmarkL. Grunnet, Steno Diabetes Center, Niels Steensens Vej1, 2820 Gentofte, DenmarkS. S. Lund, Steno Diabetes Center, Niels Steensens ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5449948</comments>
            <pubDate>Thu, 24 Nov 2011 17:44:53 +0100</pubDate>
            <guid isPermaLink="false">5449948</guid>        </item>
        <item>
            <title>The type 2 diabetes-associated variant in TCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the gene effect is modified by obesity: a meta-analysis and an individual study</title>
            <link>http://www.medworm.com/index.php?rid=5449949&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F688875p359t35w65%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;The meta-analysis demonstrates that TCF7L2 rs7903146 polymorphism is a population-independent susceptibility locus for LADA in Europeans. The effect size is similar
 for LADA and type 2 diabetes. The gene effect on diabetes risk may be modulated by BMI, such that the lower the BMI, the higher
 the gene effect.
 
 
 
 
	Content Type Journal ArticleCategory Short CommunicationPages 1-5DOI 10.1007/s00125-011-2378-zAuthors
		K. Lukacs, 1st Department of Paediatrics, Semmelweis University, Bókay u 53-54, 1083 Budapest, HungaryN. Hosszufalusi, 3rd Department of Internal Medicine, Semmelweis University, Budapest, HungaryE. Dinya, Institute of Health Informatics, Semmelweis University, Budapest, HungaryM. Bakacs, Pharmaproject-Statistics Incorporation, Budape...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5449949</comments>
            <pubDate>Tue, 22 Nov 2011 17:56:46 +0100</pubDate>
            <guid isPermaLink="false">5449949</guid>        </item>
        <item>
            <title>Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians</title>
            <link>http://www.medworm.com/index.php?rid=5449950&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw2364w4664351657%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;
 FTO is associated with increased risk of obesity and type 2 diabetes, with effect sizes similar in East and South Asians and
 similar to those observed in Europeans. Furthermore, FTO is also associated with type 2 diabetes independently of BMI.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-15DOI 10.1007/s00125-011-2370-7Authors
		H. Li, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 294 Tai-Yuan Road, Shanghai, 200031 People’s Republic of ChinaT. O. Kilpeläinen, MRC Epidemiology Unit, Institute of Metabolic Science Box 285, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 0QQ UKC. Liu, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, C...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5449950</comments>
            <pubDate>Tue, 22 Nov 2011 17:56:45 +0100</pubDate>
            <guid isPermaLink="false">5449950</guid>        </item>
        <item>
            <title>Subcellular lipid droplet distribution in red and white muscles in the obese Zucker rat</title>
            <link>http://www.medworm.com/index.php?rid=5441598&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff72xn73l8m121644%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Lipid accumulation in the subsarcolemmal region is not necessary for insulin resistance. In the intermyofibrillar compartment,
 the diversion of lipids away from mitochondria in insulin-resistant animals probably contributes to lipid accumulation in
 this subcellular area.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2367-2Authors
		J. S. V. Lally, Department of Human Health and Nutritional Science, University of Guelph, Guelph, ON, Canada N1G 2W1L. A. Snook, Department of Human Health and Nutritional Science, University of Guelph, Guelph, ON, Canada N1G 2W1X. X. Han, Department of Human Health and Nutritional Science, University of Guelph, Guelph, ON, Canada N1G 2W1A. Chabowski, Department of Physiology, Medica...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5441598</comments>
            <pubDate>Sat, 19 Nov 2011 06:51:37 +0100</pubDate>
            <guid isPermaLink="false">5441598</guid>        </item>
        <item>
            <title>Diabetes is associated with impairment of uterine contractility and high Caesarean section rate</title>
            <link>http://www.medworm.com/index.php?rid=5441599&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6687h7rnqj78404p%2F</link>
            <description>Conclusions/interpretations&amp;nbsp;&amp;nbsp;These are the first data investigating myometrium in diabetic patients and they support the hypothesis that there is poorer
 contractility even in the presence of oxytocin. The underlying mechanism is related to reduced Ca channel expression and intracellular
 calcium signals and a decrease in muscle mass. We conclude that these factors significantly contribute to the increased emergency
 CS rate in diabetic patients.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2371-6Authors
		S. Al-Qahtani, Department of Molecular and Cellular Physiology, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool, L69 3BX UKA. Heath, Department of Molecular and Cellular Physiology, Institute of Tran...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5441599</comments>
            <pubDate>Sat, 19 Nov 2011 06:51:35 +0100</pubDate>
            <guid isPermaLink="false">5441599</guid>        </item>
        <item>
            <title>Erratum to: Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4</title>
            <link>http://www.medworm.com/index.php?rid=5432222&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc423265845tw4868%2F</link>
            <description>Content Type Journal ArticleCategory ErratumPages 1-1DOI 10.1007/s00125-011-2375-2Authors
		M. N. Pham, Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University Duesseldorf, Auf’m Hennekamp 65, 40225 Duesseldorf, GermanyM. I. Hawa, Blizard Institute of Cell and Molecular Science, London, UKC. Pfleger, Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University Duesseldorf, Auf’m Hennekamp 65, 40225 Duesseldorf, GermanyM. Roden, Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University Duesseldorf, Auf’m Hennekamp 65, 40225 Duesseldorf, GermanyG. Schernthaner, Department of Medicine ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5432222</comments>
            <pubDate>Fri, 18 Nov 2011 06:54:51 +0100</pubDate>
            <guid isPermaLink="false">5432222</guid>        </item>
        <item>
            <title>Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy</title>
            <link>http://www.medworm.com/index.php?rid=5432221&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl1341377ml960p58%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;We show for the first time that renal and circulating NSA2/NSA2 levels are increased in hyperglycaemia in experimental models of diabetes, and that circulating NSA2 is elevated in DN patients with albuminuria. Further studies will be required to assess whether NSA2 plays a role in the
 pathogenesis of DN.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2373-4Authors
		R. Shahni, Diabetes Research Group, Division of Diabetes and Nutritional Sciences, School of Medicine, Kings College London, Hodgkin Building, London Bridge, London, SE1 1UL UKL. Gnudi, Cardiovascular Division, School of Medicine, Kings College London, London, UKA. King, Diabetes Research Group, Division of Diabetes and Nutritional Sciences, School of Medicine, Kings...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5432221</comments>
            <pubDate>Fri, 18 Nov 2011 06:54:51 +0100</pubDate>
            <guid isPermaLink="false">5432221</guid>        </item>
        <item>
            <title>An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10 years of age</title>
            <link>http://www.medworm.com/index.php?rid=5432224&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb6246j8788671x53%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Seroconversion to (persistent) Ab+ occurs regardless of age. Although the progression rate to diabetes is higher under age 10&amp;nbsp;years, later seroconverters (up
 to age 40&amp;nbsp;years) have similar characteristics when compared with age-matched initially Ab+ relatives and generate an important minority of prediabetic relatives, warranting their identification and, eventually, enrolment
 in prevention trials.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-8DOI 10.1007/s00125-011-2376-1Authors
		I. Vermeulen, Diabetes Research Center, Brussels Free University, VUB, Laarbeeklaan 103, 1090 Brussels, BelgiumI. Weets, Diabetes Research Center, Brussels Free University, VUB, Laarbeeklaan 103, 1090 Brussels, BelgiumO. Costa, Department of Clinic...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5432224</comments>
            <pubDate>Fri, 18 Nov 2011 06:54:50 +0100</pubDate>
            <guid isPermaLink="false">5432224</guid>        </item>
        <item>
            <title>Early insulin therapy prevents beta cell loss in a mouse model for permanent neonatal diabetes (Munich Ins2C95S)</title>
            <link>http://www.medworm.com/index.php?rid=5432223&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkjw12652q833064v%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;We conclude that early insulin treatment protects Munich Ins2
 C95S mutant mice from insulin resistance, alpha cell hyperfunction, beta cell loss and hyperplasia of non-beta cells, some well-known
 features of human diabetes mellitus. Therefore, insulin treatment may be considered early for human patients harbouring INS mutations.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2362-7Authors
		S. Kautz, Institute of Veterinary Pathology, Ludwig-Maximilians-Universität München, Veterinärstr. 13, 80539 Munich, GermanyL. van Bürck, Institute of Veterinary Pathology, Ludwig-Maximilians-Universität München, Veterinärstr. 13, 80539 Munich, GermanyM. Schuster, Institute of Veterinary Pathology, Ludwig-Maximilians-Universität Mü...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5432223</comments>
            <pubDate>Fri, 18 Nov 2011 06:54:50 +0100</pubDate>
            <guid isPermaLink="false">5432223</guid>        </item>
        <item>
            <title>Common variation in oxidative phosphorylation genes is not a major cause of insulin resistance or type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5432225&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj8w433717687u14v%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;We cannot rule out the possibility that common variants in or near OxPhos genes may influence beta cell function in non-diabetic
 individuals. However, our quantitative trait studies and a sufficiently large meta-analysis indicate that common variation
 in proximity to the examined OxPhos genes is not a major cause of insulin resistance or type 2 diabetes.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-9DOI 10.1007/s00125-011-2377-0Authors
		L. S. Snogdal, Diabetes Research Centre, Department of Endocrinology, Odense University Hospital, Kløvervænget 6, 4th Floor, 5000 Odense, DenmarkM. Wod, Diabetes Research Centre, Department of Endocrinology, Odense University Hospital, Kløvervænget 6, 4th Floor, 5000 Odense, DenmarkN. Grarup, The ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5432225</comments>
            <pubDate>Fri, 18 Nov 2011 06:54:48 +0100</pubDate>
            <guid isPermaLink="false">5432225</guid>        </item>
        <item>
            <title>Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice</title>
            <link>http://www.medworm.com/index.php?rid=5432226&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa641n2844x813n24%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;This study demonstrates a new role for arctigenin as a potent indirect activator of AMPK via inhibition of respiratory complex
 I, with beneficial effects on metabolic disorders in ob/ob mice. This highlights the potential value of arctigenin as a possible treatment of type 2 diabetes.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-13DOI 10.1007/s00125-011-2366-3Authors
		S.-L. Huang, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zu Chong Zhi Road 555, Shanghai, 201203 People’s Republic of ChinaR.-T. Yu, Northwest Plateau of Biology Institute, Chinese Academy of Sciences, 59 Xiguan Street, Xining, 810008 People’s Republic of ChinaJ. Gong, State Key Laboratory of Drug Research...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5432226</comments>
            <pubDate>Fri, 18 Nov 2011 06:54:47 +0100</pubDate>
            <guid isPermaLink="false">5432226</guid>        </item>
        <item>
            <title>Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice</title>
            <link>http://www.medworm.com/index.php?rid=5422719&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd250876r43335gu4%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Our results clearly demonstrate that kidney-targeting Smad7 gene transfer may be an effective therapy for type 2 diabetic nephropathy, acting via simultaneous modulation of the TGF-β/SMAD
 and NF-κB signalling pathways.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2364-5Authors
		S. M. Ka, Graduate Institute of Aerospace and Undersea Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of ChinaY. C. Yeh, Graduate Institute of Life Sciences, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of ChinaX. R. Huang, Department of Medicine and Therapeutics and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, H...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5422719</comments>
            <pubDate>Tue, 15 Nov 2011 16:49:07 +0100</pubDate>
            <guid isPermaLink="false">5422719</guid>        </item>
        <item>
            <title>The joint association of physical activity and glycaemic control in predicting cardiovascular death and all-cause mortality in the US population</title>
            <link>http://www.medworm.com/index.php?rid=5409156&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa1pw221q0246h407%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Physical activity is associated with lower all-cause and CVD mortality risk for individuals across all levels of glycaemic
 control. Therefore, engaging in a physically active lifestyle and achieving normal levels of glycaemic control may both be
 important for the prevention of early mortality.
 
 
 
 
	Content Type Journal ArticleCategory Short CommunicationPages 1-4DOI 10.1007/s00125-011-2374-3Authors
		J. I. Reddigan, School of Kinesiology and Health Science, 2002 Sherman Health Science Centre, York University, 4700 Keele Street, Toronto, ON, Canada M3J 1P3M. C. Riddell, School of Kinesiology and Health Science, York University, Norman Bethune College, Toronto, ON, CanadaJ. L. Kuk, School of Kinesiology and Health Science, 2002 Sherman Health Scien...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409156</comments>
            <pubDate>Sun, 13 Nov 2011 06:48:47 +0100</pubDate>
            <guid isPermaLink="false">5409156</guid>        </item>
        <item>
            <title>Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy</title>
            <link>http://www.medworm.com/index.php?rid=5409157&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe6847703h6g421qt%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Postprandial glucose control is impaired by significantly slower glucose disposal in late gestation. Early prandial insulin
 dosing may help to accelerate glucose disposal and potentially ameliorate postprandial hyperglycaemia in late pregnancy.
 
 
 
 Trial registration: ISRCTN 62568875
 
 
 
 
 Funding: Diabetes UK Project Grant BDA 07/003551. H.R. Murphy is funded by a National Institute for Health Research (NIHR) research
 fellowship (PDF/08/01/036). Supported also by the Juvenile Diabetes Research Foundation (JDRF), Abbott Diabetes Care (Freestyle
 Navigator CGM and sensors free of charge), Medical Research Council Centre for Obesity and Related Metabolic Diseases and
 NIHR Cambridge Biomedical Research Centre.
 
 
 
 
 
	Content Type Journal Arti...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409157</comments>
            <pubDate>Sat, 12 Nov 2011 06:47:48 +0100</pubDate>
            <guid isPermaLink="false">5409157</guid>        </item>
        <item>
            <title>Diabetes: impaired damage control</title>
            <link>http://www.medworm.com/index.php?rid=5409158&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F32u6182850025090%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A coordinated response by the innate immune system, (micro)circulation and nervous system is needed to limit tissue destruction
 and to initiate reparative processes after tissue damage. Alterations in danger signals in diabetes can be an important cause
 of the excessive tissue loss and defective tissue repair after injury and can contribute to the higher rates of cardiac failure
 after myocardial infarction, more severe tissue loss in the case of peripheral ischaemia and impaired wound healing. Here
 we discuss the mechanisms underlying this impaired damage control in diabetes, with an emphasis on the proinflammatory cytokine
 high mobility group box 1 and the potential role of dipeptidyl peptidase IV inhibition in improving repair responses.
 
 
	Content Type Journal...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409158</comments>
            <pubDate>Fri, 11 Nov 2011 16:45:05 +0100</pubDate>
            <guid isPermaLink="false">5409158</guid>        </item>
        <item>
            <title>The functional and molecular characterisation of human embryonic stem cell-derived insulin-positive cells compared with adult pancreatic beta cells</title>
            <link>http://www.medworm.com/index.php?rid=5409160&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn1j80tv730411037%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;INS:GFP+ cells can be purified from differentiated hESCs, providing a superior source of insulin-producing cells. Genomic analyses
 revealed that INS:GFP+ cells collectively resemble immature endocrine cells. However, insulin+ cells were heterogeneous, a fact that translated into important functional differences within this population. The information
 gained from this study may now be used to generate new iterations of functioning beta cells that can be purified for transplant.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-14DOI 10.1007/s00125-011-2335-xAuthors
		C. L. Basford, Division of Cellular and Molecular Biology, Toronto General Research Institute, TMDT, Toronto, ON, CanadaK. J. Prentice, Division of Cellular and Molecular Biolo...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409160</comments>
            <pubDate>Thu, 10 Nov 2011 16:50:14 +0100</pubDate>
            <guid isPermaLink="false">5409160</guid>        </item>
        <item>
            <title>Autophagy deficiency in beta cells leads to compromised unfolded protein response and progression from obesity to diabetes in mice</title>
            <link>http://www.medworm.com/index.php?rid=5409159&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx538373x50264978%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;These results suggest that autophagy is important for intact UPR machinery and appropriate UPR in response to lipid injury
 that increases demand for UPR. Autophagy deficiency in pancreatic beta cells may contribute to the progression from obesity
 to diabetes.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-12DOI 10.1007/s00125-011-2350-yAuthors
		W. Quan, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Kangnam-ku, Seoul, 135-710 South KoreaK. Y. Hur, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Kangnam-ku, Seoul, 135-710 South KoreaY. Lim, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School o...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409159</comments>
            <pubDate>Thu, 10 Nov 2011 16:50:14 +0100</pubDate>
            <guid isPermaLink="false">5409159</guid>        </item>
        <item>
            <title>Reversible severe deterioration of glycaemic control after withdrawal of metformin treatment</title>
            <link>http://www.medworm.com/index.php?rid=5409162&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F62m0618226857k51%2F</link>
            <description>Content Type Journal ArticleCategory Research LetterPages 1-3DOI 10.1007/s00125-011-2351-xAuthors
		Z. Panossian, Auckland Diabetes Centre, Greenlane Clinical Centre, PO Box 92189, Auckland, 1142 New ZealandP. L. Drury, Auckland Diabetes Centre, Greenlane Clinical Centre, PO Box 92189, Auckland, 1142 New ZealandT. Cundy, Auckland Diabetes Centre, Greenlane Clinical Centre, PO Box 92189, Auckland, 1142 New Zealand
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia)</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409162</comments>
            <pubDate>Thu, 10 Nov 2011 06:45:25 +0100</pubDate>
            <guid isPermaLink="false">5409162</guid>        </item>
        <item>
            <title>Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice</title>
            <link>http://www.medworm.com/index.php?rid=5409161&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Feumv30605350vw48%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Our results suggest that the ability of DPP-4 inhibition to suppress the progression to STZ-induced hyperglycaemia involves
 both alleviation of beta cell death and alpha cell proliferation.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-9DOI 10.1007/s00125-011-2365-4Authors
		Y. Takeda, Division of Metabolism and Biosystemic Science, Department of Internal Medicine, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, 078-8510 JapanY. Fujita, Division of Metabolism and Biosystemic Science, Department of Internal Medicine, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, 078-8510 JapanJ. Honjo, Division of Metabolism and Biosystemic Science, Department of Internal Medicine, Asahikawa Medical Universit...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409161</comments>
            <pubDate>Thu, 10 Nov 2011 06:45:25 +0100</pubDate>
            <guid isPermaLink="false">5409161</guid>        </item>
        <item>
            <title>Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss</title>
            <link>http://www.medworm.com/index.php?rid=5388082&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl172xj644433m477%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;A cluster of metabolites comprising BCAAs and related analytes predicts improvement in HOMA-IR independent of the amount of
 weight lost. These results may help identify individuals most likely to benefit from moderate weight loss and elucidate novel
 mechanisms of IR in obesity.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2356-5Authors
		S. H. Shah, Department of Medicine, DUMC, Duke University Medical Center, Box 3445, Durham, NC 27710, USAD. R. Crosslin, Department of Biostatistics, University of Washington, Seattle, WA, USAC. S. Haynes, Center for Human Genetics, Duke University Medical Center, Durham, NC, USAS. Nelson, Department of Biostatistics, University of Washington, Seattle, WA, USAC. B. Turer, Depa...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5388082</comments>
            <pubDate>Mon, 07 Nov 2011 16:59:57 +0100</pubDate>
            <guid isPermaLink="false">5388082</guid>        </item>
        <item>
            <title>Audit of acute Charcot’s disease in the UK: the CDUK study</title>
            <link>http://www.medworm.com/index.php?rid=5388083&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4711p181g7v770ju%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;The median time to resolution was longer than in earlier series. Although limited by being observational and non-randomised,
 these data suggest that the use of non-removable off-loading at presentation may shorten the time to resolution. They provide
 no evidence to indicate that the use of bisphosphonates is beneficial.
 
 
 
 
	Content Type Journal ArticleCategory Short CommunicationPages 1-4DOI 10.1007/s00125-011-2354-7Authors
		F. L. Game, Foot Ulcer Trials Unit, Department of Diabetes and Endocrinology, Nottingham University Hospitals Trust, City Hospital Campus, Hucknall Road, Nottingham, NG5 1PB UKR. Catlow, East Lancashire Healthcare Trust, Blackburn, UKG. R. Jones, East Lancashire Healthcare Trust, Blackburn, UKM. E. Edmonds, Kings College Ho...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5388083</comments>
            <pubDate>Mon, 07 Nov 2011 16:59:56 +0100</pubDate>
            <guid isPermaLink="false">5388083</guid>        </item>
        <item>
            <title>Early adulthood television viewing and cardiometabolic risk profiles in early middle age: results from a population, prospective cohort study</title>
            <link>http://www.medworm.com/index.php?rid=5388084&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp40232r8tn665u70%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;TV viewing habits in early adulthood are associated with adverse cardiometabolic profiles in early middle adulthood that are
 independent of TV viewing habits and physical activity in middle age, but not independent of BMI in early adulthood.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2358-3Authors
		E. Stamatakis, Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London, WC1E 6BT UKM. Hamer, Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London, WC1E 6BT UKG. D. Mishra, Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London, WC1E 6BT UK
	

	
		Journal DiabetologiaOnlin...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5388084</comments>
            <pubDate>Sat, 05 Nov 2011 17:09:31 +0100</pubDate>
            <guid isPermaLink="false">5388084</guid>        </item>
        <item>
            <title>Five-year follow-up of a cohort of people with their first diabetic foot ulcer: the persistent effect of depression on mortality</title>
            <link>http://www.medworm.com/index.php?rid=5388085&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx02r412v6r674361%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Depression is associated with a persistent twofold increased risk of mortality in people with their first DFU at 5&amp;nbsp;years.
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-8DOI 10.1007/s00125-011-2359-2Authors
		K. Winkley, Department of Psychological Medicine, King’s College London &amp; Institute of Psychiatry, Weston Education Centre, 10 Cutcombe Road, London, SE5 8AZ UKH. Sallis, Department of Biostatistics, King’s College London &amp; Institute of Psychiatry, De Crespigny Park, London, UKD. Kariyawasam, Guy’s and St Thomas’ NHS Foundation Trust, London, UKL. H. Leelarathna, Guy’s and St Thomas’ NHS Foundation Trust, London, UKT. Chalder, Department of Psychological Medicine, King’s College London &amp; Institute of Psychiatry, West...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5388085</comments>
            <pubDate>Sat, 05 Nov 2011 17:09:30 +0100</pubDate>
            <guid isPermaLink="false">5388085</guid>        </item>
        <item>
            <title>Periodontitis and diabetes: a two-way relationship</title>
            <link>http://www.medworm.com/index.php?rid=5388086&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnk42713616j20v00%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Periodontitis is a common chronic inflammatory disease characterised by destruction of the supporting structures of the teeth
 (the periodontal ligament and alveolar bone). It is highly prevalent (severe periodontitis affects 10–15% of adults) and has
 multiple negative impacts on quality of life. Epidemiological data confirm that diabetes is a major risk factor for periodontitis;
 susceptibility to periodontitis is increased by approximately threefold in people with diabetes. There is a clear relationship
 between degree of hyperglycaemia and severity of periodontitis. The mechanisms that underpin the links between these two conditions
 are not completely understood, but involve aspects of immune functioning, neutrophil activity, and cytokine biology. There
 is emerg...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5388086</comments>
            <pubDate>Sat, 05 Nov 2011 17:09:29 +0100</pubDate>
            <guid isPermaLink="false">5388086</guid>        </item>
        <item>
            <title>Building muscle, browning fat and preventing obesity by inhibiting myostatin</title>
            <link>http://www.medworm.com/index.php?rid=5388087&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F63r5453j067t450j%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The obesity epidemic is an overwhelming global health concern. Interventions to improve body weight and composition aim to
 restore balance between nutrient intake and energy expenditure. Myostatin, a powerful negative regulator of skeletal muscle
 mass, has emerged as a potential therapeutic target for obesity and type 2 diabetes mellitus because of the prominent role
 skeletal muscle plays in metabolic rate and insulin-mediated glucose disposal. In fact, inhibition of myostatin by genetic
 manipulation or pharmacological means leads to a hypermuscular and very lean build in mice. The resistance of myostatin-null
 mice to diet-induced obesity, fat mass accumulation and metabolic dysfunction has been presumed to be a result of their large
 skeletal muscle mass; however,...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5388087</comments>
            <pubDate>Sat, 05 Nov 2011 17:09:28 +0100</pubDate>
            <guid isPermaLink="false">5388087</guid>        </item>
        <item>
            <title>Association analysis of 31 common polymorphisms with type 2 diabetes and its related traits in Indian sib pairs</title>
            <link>http://www.medworm.com/index.php?rid=5388088&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F62m8822j11u7575g%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;We validated the association of seven established loci with intermediate traits related to type 2 diabetes in an Indian population
 using a design resistant to population stratification.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-9DOI 10.1007/s00125-011-2355-6Authors
		V. Gupta, South Asia Network for Chronic Disease, Public Health Foundation of India, C-1/52, Safdarjung Development Area, New Delhi, 110016 IndiaD. G. Vinay, Centre for Cellular and Molecular Biology (CCMB), Council of Scientific and Industrial Research (CSIR), Habshiguda, Uppal Road, Hyderabad, 500007 IndiaS. Rafiq, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UKM. V. Kranthikumar, Centre for Cellular and Molecu...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5388088</comments>
            <pubDate>Thu, 03 Nov 2011 16:56:40 +0100</pubDate>
            <guid isPermaLink="false">5388088</guid>        </item>
        <item>
            <title>Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=5361473&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc0812t1271g76780%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Uncertainty persists regarding the clinically relevant risks and benefits of TZDs and vitamin D because of the early cancellation
 of this comprehensive trial.
 
 
 
 
 Trial registration:&amp;nbsp;&amp;nbsp;ClinicalTrials.gov NCT00879970
 
 
 
 Funding:&amp;nbsp;&amp;nbsp;The study was funded by GlaxoSmithKline.
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2357-4Authors
		The TIDE Trial Investigators, c/o Z. Punthakee, Population Health Research Institute, McMaster University, 237 Barton St E., Hamilton, ON, Canada L8L 2X2
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia)</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361473</comments>
            <pubDate>Sat, 29 Oct 2011 05:43:28 +0100</pubDate>
            <guid isPermaLink="false">5361473</guid>        </item>
        <item>
            <title>Immunohistochemical characterisation of cells co-producing insulin and glucagon in the developing human pancreas</title>
            <link>http://www.medworm.com/index.php?rid=5361474&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd39254468m500628%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Our results indicate that cells co-producing insulin and glucagon in the developing human pancreas share a transcription factor
 profile that is similar to that of mature alpha cells and suggest that some maturing alpha cells briefly exhibit ectopic insulin
 expression. Thus cells that co-produce insulin and glucagon may represent a transient cell population, which gives rise to
 mature alpha cells.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2344-9Authors
		M. J. Riedel, Laboratory of Molecular and Cellular Medicine, Department of Cellular and Physiological Sciences, Life Sciences Institute, 2350 Health Sciences Mall, University of British Columbia, Vancouver, BC, Canada V6T 1Z3A. Asadi, Laboratory of Molecula...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361474</comments>
            <pubDate>Fri, 28 Oct 2011 16:46:03 +0100</pubDate>
            <guid isPermaLink="false">5361474</guid>        </item>
        <item>
            <title>A metabolomic study of low estimated GFR in non-proteinuric type 2 diabetes mellitus</title>
            <link>http://www.medworm.com/index.php?rid=5361476&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl5706250447805u3%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Our study has yielded substantial new insight into low eGFR and provided a collection of potential urinary biomarkers for
 its detection.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2339-6Authors
		D. P. K. Ng, Department of Epidemiology and Public Health, Yong Loo Lin School of Medicine, National University of Singapore, 16 Medical Drive MD3, Singapore, 117597 Republic of SingaporeA. Salim, Department of Epidemiology and Public Health, Yong Loo Lin School of Medicine, National University of Singapore, 16 Medical Drive MD3, Singapore, 117597 Republic of SingaporeY. Liu, Department of Epidemiology and Public Health, Yong Loo Lin School of Medicine, National University of Singapore, 16 Medical Drive MD3, Singapor...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361476</comments>
            <pubDate>Fri, 28 Oct 2011 16:46:02 +0100</pubDate>
            <guid isPermaLink="false">5361476</guid>        </item>
        <item>
            <title>Coupling factor 6-induced activation of ecto-F1Fo complex induces insulin resistance, mild glucose intolerance and elevated blood pressure in mice</title>
            <link>http://www.medworm.com/index.php?rid=5361475&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv737h1378v5nvrq5%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Through its action on the β-subunit of ecto-F1Fo complex, which results in intracellular acidosis, CF6 plays a crucial role in the development of insulin resistance and hypertension.
 This finding might advance our understanding of the mechanisms underlying diabetes and hypertension, possibly also providing
 a novel therapeutic target against cardiovascular disease.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2341-zAuthors
		T. Osanai, Department of Cardiology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562 JapanM. Tanaka, Department of Cardiology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562 JapanK. Magota, Asubio Pharma, Faculty of Discove...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361475</comments>
            <pubDate>Fri, 28 Oct 2011 16:46:02 +0100</pubDate>
            <guid isPermaLink="false">5361475</guid>        </item>
        <item>
            <title>Remembering our classics: then and now</title>
            <link>http://www.medworm.com/index.php?rid=5361477&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu325112606447578%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-2DOI 10.1007/s00125-011-2349-4Authors
		J. R. Zierath, Department of Molecular Medicine and Surgery, Section of Integrative Physiology, Karolinska Institutet, von Eulers väg 4, 4th Floor, 171 77 Stockholm, Sweden
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia)</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361477</comments>
            <pubDate>Fri, 28 Oct 2011 16:45:58 +0100</pubDate>
            <guid isPermaLink="false">5361477</guid>        </item>
        <item>
            <title>cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets</title>
            <link>http://www.medworm.com/index.php?rid=5361479&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3t1g0547681mv716%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Islet amyloid formation induces JNK activation, which upregulates predominantly pro-apoptotic signals in both extrinsic and
 intrinsic pathways, resulting in beta cell apoptosis.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-9DOI 10.1007/s00125-011-2338-7Authors
		S. L. Subramanian, Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, 1660 South Columbian Way, Seattle, WA 98108, USAR. L. Hull, Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, 1660 South Columbian Way, Seattle, WA 98108, USAS. Zraika, Division of Metabolism, Endocrinology, and Nutrition, Depart...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361479</comments>
            <pubDate>Fri, 28 Oct 2011 16:45:56 +0100</pubDate>
            <guid isPermaLink="false">5361479</guid>        </item>
        <item>
            <title>Ubiquitin C-terminal hydrolase L1 is required for pancreatic beta cell survival and function in lipotoxic conditions</title>
            <link>http://www.medworm.com/index.php?rid=5361478&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb2445545415m6101%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Together, these data suggest that UCHL1 has essential functional and anti-apoptotic roles in beta cells under stress conditions
 associated with lipotoxicity.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-13DOI 10.1007/s00125-011-2323-1Authors
		K. Y. Chu, Laboratory of Molecular Signaling in Diabetes, Diabetes Research Group, Department of Cellular and Physiological Sciences, University of British Columbia, 5358 Life Sciences Building, 2350 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3H. Li, Laboratory of Molecular Signaling in Diabetes, Diabetes Research Group, Department of Cellular and Physiological Sciences, University of British Columbia, 5358 Life Sciences Building, 2350 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3K. ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361478</comments>
            <pubDate>Fri, 28 Oct 2011 16:45:56 +0100</pubDate>
            <guid isPermaLink="false">5361478</guid>        </item>
        <item>
            <title>Common genetic variants differentially influence the transition from clinically defined states of fasting glucose metabolism</title>
            <link>http://www.medworm.com/index.php?rid=5361480&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fat07554l12382w08%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Common genetic risk variants at GCK, SLC30A8, IGF2BP2 and MTNR1B influence to different extents the development of IFG and the transition from IFG to type 2 diabetes. Our findings may have
 implications for understanding the genetic contribution of these variants to the development of IFG and type 2 diabetes.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-9DOI 10.1007/s00125-011-2353-8Authors
		G. A. Walford, Center for Human Genetic Research, Simches Research Building—CPZN 5.250, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USAT. Green, Center for Human Genetic Research, Simches Research Building—CPZN 5.250, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USAB. Neale, Center for Huma...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361480</comments>
            <pubDate>Fri, 28 Oct 2011 16:45:51 +0100</pubDate>
            <guid isPermaLink="false">5361480</guid>        </item>
        <item>
            <title>Antidepressant drug use and future diabetes risk</title>
            <link>http://www.medworm.com/index.php?rid=5361481&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F236165155l45r84r%2F</link>
            <description>Content Type Journal ArticleCategory CommentaryPages 1-3DOI 10.1007/s00125-011-2360-9Authors
		M. Kivimäki, Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, WC1E 6BT London, UKG. D. Batty, Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, WC1E 6BT London, UK
	

	
		Journal DiabetologiaOnline ISSN 1432-0428Print ISSN 0012-186X (Source: Diabetologia)</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361481</comments>
            <pubDate>Fri, 28 Oct 2011 16:45:50 +0100</pubDate>
            <guid isPermaLink="false">5361481</guid>        </item>
        <item>
            <title>Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk</title>
            <link>http://www.medworm.com/index.php?rid=5361482&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F91654760467r6871%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Our study suggests the common human P446L-GKRP variant protein results in elevated hepatic glucose uptake and disposal by
 increasing active cytosolic GCK. This would increase hepatic lipid biosynthesis but decrease fasting plasma glucose concentrations
 and provides a potential mechanism for the protective effect of this allele on type 2 diabetes risk.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-9DOI 10.1007/s00125-011-2348-5Authors
		M. G. Rees, Oxford Centre for Diabetes Endocrinology &amp; Metabolism, University of Oxford, Churchill Hospital, Headington, Oxford, OX3 7LJ UKS. Wincovitch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USAJ. Schultz, Institute for Medical Biochemistry &amp; Molecular Bi...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361482</comments>
            <pubDate>Fri, 28 Oct 2011 16:45:44 +0100</pubDate>
            <guid isPermaLink="false">5361482</guid>        </item>
        <item>
            <title>Insulin analogues and cancer risk: the emergence of second-generation studies</title>
            <link>http://www.medworm.com/index.php?rid=5361483&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl3878j174q8h101t%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A number of observational studies have linked insulin glargine (A21Gly,B31Arg,B32Arg human insulin) with a putative increased
 cancer risk, particularly breast cancer, but many of these ‘first generation’ studies had study design and analysis flaws,
 and were inconclusive. A small number of ‘second generation’ studies are now emerging in which the applied pharmaco-epidemiological
 principles are more robust. For example, when Ruitar and colleagues (Diabetologia DOI:10.1007/s00125-011-2312-4) focused specifically on breast cancer rather than all incident cancer risk, they were able to show a positive association
 with insulin glargine for breast cancer although there was no association with all incident cancer risk. A list of preferred
 qualities for pharmaco-epi...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361483</comments>
            <pubDate>Fri, 28 Oct 2011 06:04:15 +0100</pubDate>
            <guid isPermaLink="false">5361483</guid>        </item>
        <item>
            <title>Purchase of antidepressant agents by patients with type 1 diabetes is associated with increased mortality rates in women but not in men</title>
            <link>http://www.medworm.com/index.php?rid=5361484&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu7858x67571m8166%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;In a population of patients with type 1 diabetes, purchase of antidepressant agents was associated with increased mortality
 rates in women, but not in men.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-7DOI 10.1007/s00125-011-2347-6Authors
		A. J. Ahola, Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, University of Helsinki, PO Box 63, 00014 Helsinki, FinlandV. Harjutsalo, Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, University of Helsinki, PO Box 63, 00014 Helsinki, FinlandM. Saraheimo, Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, University of Helsinki, PO Box 63, 00014 Helsinki, FinlandC. Forsblom, Folkhälsan Institut...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361484</comments>
            <pubDate>Fri, 28 Oct 2011 06:04:13 +0100</pubDate>
            <guid isPermaLink="false">5361484</guid>        </item>
        <item>
            <title>Racial and ethnic disparities in diabetes risk after gestational diabetes mellitus</title>
            <link>http://www.medworm.com/index.php?rid=5348401&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8xj3246520231l54%2F</link>
            <description>Conclusions/interpretations&amp;nbsp;&amp;nbsp;Racial/ethnic disparities exist in risk of diabetes after GDM. Black women with GDM had the highest risk of developing diabetes.
 This highlights the importance of developing an effective diabetes screening and prevention programme in women with GDM, particularly
 black women with GDM.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-6DOI 10.1007/s00125-011-2330-2Authors
		A. H. Xiang, Department of Research &amp; Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 5th Floor, Pasadena, CA 91101, USAB. H. Li, Department of Research &amp; Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 5th Floor, Pasadena, CA 91101, USAM. H. Black, Department of Research &amp; Evaluation, Kaiser Permanente Southern California, 100...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5348401</comments>
            <pubDate>Thu, 20 Oct 2011 15:52:21 +0100</pubDate>
            <guid isPermaLink="false">5348401</guid>        </item>
        <item>
            <title>Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy</title>
            <link>http://www.medworm.com/index.php?rid=5348402&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff7800361511w44u3%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;The WNT pathway is activated in the kidneys of models of both type 1 and 2 diabetes. Dysregulation of the WNT pathway in diabetes
 represents a new pathogenic mechanism of diabetic nephropathy and renders a new therapeutic target.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-12DOI 10.1007/s00125-011-2314-2Authors
		T. Zhou, Department of Biochemistry, Zhongshan Medical School, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaX. He, Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USAR. Cheng, Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USAB. Zhang, Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma Ci...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5348402</comments>
            <pubDate>Thu, 20 Oct 2011 15:52:19 +0100</pubDate>
            <guid isPermaLink="false">5348402</guid>        </item>
        <item>
            <title>Exposure to the common food additive carrageenan leads to glucose intolerance, insulin resistance and inhibition of insulin signalling in HepG2 cells and C57BL/6J mice</title>
            <link>http://www.medworm.com/index.php?rid=5336740&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx4055n886835344k%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This is the first report of the impact of carrageenan on glucose tolerance and indicates that carrageenan impairs glucose
 tolerance, increases insulin resistance and inhibits insulin signalling in vivo in mouse liver and human HepG2 cells. These
 effects may result from carrageenan-induced inflammation. The results demonstrate extra-colonic manifestations of ingested
 carrageenan and suggest that carrageenan in the human diet may contribute to the development of diabetes.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2333-zAuthors
		S. Bhattacharyya, Department of Medicine, University of Illinois at Chicago, 840 South Wood Street, CSN 440, M/C 718, Chicago, IL 60612, USAI. O-Sullivan, Jesse Brown VA Medical Center, Chicago, IL,...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5336740</comments>
            <pubDate>Wed, 19 Oct 2011 15:46:42 +0100</pubDate>
            <guid isPermaLink="false">5336740</guid>        </item>
        <item>
            <title>Metformin-treated patients with type 2 diabetes have normal mitochondrial complex I respiration</title>
            <link>http://www.medworm.com/index.php?rid=5336741&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fyhr2575u01g7865t%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Metformin treatment does not inhibit mitochondrial complex I respiration in the electron transport chain in human skeletal
 muscle of patients with type 2 diabetes when measured ex vivo. Inhibition of complex I and II respiration in controls was
 demonstrated by metformin titration in vitro at doses well above those observed during metformin treatment.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-7DOI 10.1007/s00125-011-2340-0Authors
		S. Larsen, Xlab, Center for Healthy Aging, Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen N, DenmarkR. Rabøl, Xlab, Center for Healthy Aging, Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5336741</comments>
            <pubDate>Wed, 19 Oct 2011 05:56:51 +0100</pubDate>
            <guid isPermaLink="false">5336741</guid>        </item>
        <item>
            <title>Erratum to: Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-γ (PPAR-γ)-deficient mice</title>
            <link>http://www.medworm.com/index.php?rid=5336742&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F621530w5t4001145%2F</link>
            <description>Content Type Journal ArticleCategory ErratumPages 1-2DOI 10.1007/s00125-011-2337-8Authors
		S. Z. Duan, Department of Internal Medicine, Nephrology Division, University of Michigan Medical School, Ann Arbor, MI, USAM. G. Usher, Department of Molecular and Integrative Physiology, University of Michigan Medical School, 7641 Med. Sci. II, 1150W. Med. Ctr. Dr, Ann Arbor, MI 48109-5622, USAE. L. Foley, Department of Molecular and Integrative Physiology, University of Michigan Medical School, 7641 Med. Sci. II, 1150W. Med. Ctr. Dr, Ann Arbor, MI 48109-5622, USAD. S. Milstone, Vascular Research Division, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USAF. C. Brosius, Department of Internal Medicine, Nephrology Division, University of Michigan Medic...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5336742</comments>
            <pubDate>Tue, 18 Oct 2011 15:58:31 +0100</pubDate>
            <guid isPermaLink="false">5336742</guid>        </item>
        <item>
            <title>Increased hexosamine biosynthetic pathway flux dedifferentiates INS-1E cells and murine islets by an extracellular signal-regulated kinase (ERK)1/2-mediated signal transmission pathway</title>
            <link>http://www.medworm.com/index.php?rid=5336743&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd171uh45317p2h5m%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Glucotoxic ER stress dedifferentiates beta cells, in the absence of apoptosis, through a transcriptional response. These effects
 are mediated by the activation of ERK1/2.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-13DOI 10.1007/s00125-011-2315-1Authors
		A. Lombardi, Dipartimento di Scienze e Tecnologie Biologiche e Ambientali, Università degli Studi del Salento, 73100 Lecce, ItalyL. Ulianich, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università degli Studi di Napoli Federico II, Naples, ItalyA. S. Treglia, Dipartimento di Scienze e Tecnologie Biologiche e Ambientali, Università degli Studi del Salento, 73100 Lecce, ItalyC. Nigro, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università degli Stu...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5336743</comments>
            <pubDate>Tue, 18 Oct 2011 05:49:00 +0100</pubDate>
            <guid isPermaLink="false">5336743</guid>        </item>
        <item>
            <title>Endoplasmic reticulum stress does not mediate palmitate-induced insulin resistance in mouse and human muscle cells</title>
            <link>http://www.medworm.com/index.php?rid=5336744&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5456104m646k6g50%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;These data show that insulin resistance induced by palmitate is not related to ER stress in muscle cells.
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2328-9Authors
		R. Hage Hassan, Inserm, UMR-S 872, Centre de Recherche des Cordeliers, Paris, 75006 FranceI. Hainault, Inserm, UMR-S 872, Centre de Recherche des Cordeliers, Paris, 75006 FranceJ.-T. Vilquin, Université Pierre et Marie Curie, Groupe Hospitalier Pitié-Salpêtrière, Paris, FranceC. Samama, Inserm, UMR-S 872, Centre de Recherche des Cordeliers, Paris, 75006 FranceF. Lasnier, Inserm, UMR-S 872, Centre de Recherche des Cordeliers, Paris, 75006 FranceP. Ferré, Inserm, UMR-S 872, Centre de Recherche des Cordeliers, Paris, 75006 FranceF. Foufelle, Inserm...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5336744</comments>
            <pubDate>Tue, 18 Oct 2011 05:48:59 +0100</pubDate>
            <guid isPermaLink="false">5336744</guid>        </item>
        <item>
            <title>Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients</title>
            <link>http://www.medworm.com/index.php?rid=5324417&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0123k82p17581402%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Insulin detemir induces significant and sustained weight loss, which is first observed at 1&amp;nbsp;week after changing from NPH insulin.
 The initial weight loss seems to be related to changes in fluid volume and may reflect changed insulin action in the kidneys.
 
 
 
 
 Trial registration:&amp;nbsp;&amp;nbsp;EudraCT 2008-001602-16; ClinicalTrials.gov NCT00742976
 
 
 
 Funding:&amp;nbsp;&amp;nbsp;The study was funded by a Libra Grant from NovoNordisk, DK.
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-5DOI 10.1007/s00125-011-2345-8Authors
		K. V. Hendriksen, Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkT. Jensen, Department of Endocrinology, Rigshospitalet, Blegdamsvej 9, DK-2100 København Ø, DenmarkP. Oturai, De...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5324417</comments>
            <pubDate>Sat, 15 Oct 2011 15:47:11 +0100</pubDate>
            <guid isPermaLink="false">5324417</guid>        </item>
        <item>
            <title>Insulin entry into muscle involves a saturable process in the vascular endothelium</title>
            <link>http://www.medworm.com/index.php?rid=5324418&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F73n8p612503158j0%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;These results indicate that insulin's trans-endothelial movement within muscle is a saturable process, which is likely to
 involve the insulin receptor. Current findings, together with other recent reports, suggest that trans-endothelial insulin
 transport may be an important site at which muscle insulin action is modulated in clinical and pathological settings.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-7DOI 10.1007/s00125-011-2343-xAuthors
		S. Majumdar, University of Virginia Health System, PO Box 801410, 450 Ray C. Hunt Drive, Charlottesville, VA 22908, USAA. J. Genders, University of Virginia Health System, PO Box 801410, 450 Ray C. Hunt Drive, Charlottesville, VA 22908, USAA. C. Inyard, University of Virginia Health System, PO B...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5324418</comments>
            <pubDate>Sat, 15 Oct 2011 05:53:56 +0100</pubDate>
            <guid isPermaLink="false">5324418</guid>        </item>
        <item>
            <title>Deconstructing obesity: the face of fatness before and after the discovery of leptin</title>
            <link>http://www.medworm.com/index.php?rid=5324419&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn325000036186121%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The prevalence and severity of obesity have increased to epidemic proportions around the globe, and over two-thirds of the
 US population grapples with either being overweight or obese. Obesity and its comorbidities not only subtract from quality
 of overall life, but also claim a substantial cost to life. In this edition of ‘Then and now’, two seminal papers by D.L.
 Coleman, ‘The influence of genetic background on the expression of the obese (ob) gene in the mouse’ and ‘Effects of parabiosis of obese with diabetes and normal mice’, which featured in Diabetologia in 1973, are appraised for their merit and foresight regarding the present eruption of research into what has consequently
 been labelled ‘the metabolic syndrome’. These two studies determined ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5324419</comments>
            <pubDate>Sat, 15 Oct 2011 05:53:55 +0100</pubDate>
            <guid isPermaLink="false">5324419</guid>        </item>
        <item>
            <title>Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5324420&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fwvn0q30684360010%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Higher RDW values are associated with increased odds of developing cardiovascular disease and nephropathy in a nationally
 representative sample of USA adults with diabetes. RDW may be an important clinical marker of vascular complications in diabetes
 and one that is independent of traditional risk factors and disease duration.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2331-1Authors
		N. Malandrino, Division of Endocrinology, Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USAW. C. Wu, Center on Systems, Outcomes and Quality in Chronic Disease and Rehabilitation, Research Enhancement Award Program, Providence Veterans Affairs Medical Center, Providence, RI, USAT. H. ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5324420</comments>
            <pubDate>Sat, 15 Oct 2011 05:53:54 +0100</pubDate>
            <guid isPermaLink="false">5324420</guid>        </item>
        <item>
            <title>Fat-induced membrane cholesterol accrual provokes cortical filamentous actin destabilisation and glucose transport dysfunction in skeletal muscle</title>
            <link>http://www.medworm.com/index.php?rid=5324421&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm8l63l37654k1432%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Our results suggest a novel cholesterolgenic-based mechanism of FA-induced membrane/cytoskeletal disorder and insulin resistance.
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2334-yAuthors
		K. M. Habegger, Department of Cellular and Integrative Physiology, Indiana University School of Medicine, VanNuys Medical Science Building Rm 308A, 635 Barnhill Drive, Indianapolis, IN 46202-5120, USAB. A. Penque, Department of Cellular and Integrative Physiology, Indiana University School of Medicine, VanNuys Medical Science Building Rm 308A, 635 Barnhill Drive, Indianapolis, IN 46202-5120, USAW. Sealls, Department of Cellular and Integrative Physiology, Indiana University School of Medicine, VanNuys Medical Science Building ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5324421</comments>
            <pubDate>Sat, 15 Oct 2011 05:53:53 +0100</pubDate>
            <guid isPermaLink="false">5324421</guid>        </item>
        <item>
            <title>Amylin and leptin activate overlapping signalling pathways in an additive manner in mouse GT1-7 hypothalamic, C2C12 muscle and AML12 liver cell lines</title>
            <link>http://www.medworm.com/index.php?rid=5324422&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq72l60264w8288v8%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Our data suggest that leptin and amylin have overlapping and additive, but not synergistic, effects in the activation of intracellular
 signalling pathways. ER stress may induce leptin and amylin resistance in hypothalamic, muscle and liver cell lines. These
 novel insights into the mode of action of leptin and amylin suggest that these hormones may play an additive role in regulating
 energy homeostasis in humans.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2332-0Authors
		H.-S. Moon, Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USAJ. P. Chamberland, Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medic...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5324422</comments>
            <pubDate>Fri, 14 Oct 2011 05:50:28 +0100</pubDate>
            <guid isPermaLink="false">5324422</guid>        </item>
        <item>
            <title>AMP-activated protein kinase mediates effects of oxidative stress on embryo gene expression in a mouse model of diabetic embryopathy</title>
            <link>http://www.medworm.com/index.php?rid=5324423&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff1q664784p752785%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Stimulation of AMPK in embryos during a diabetic pregnancy mediates the effects of hyperglycaemia-induced oxidative stress
 to disturb the expression of the critical Pax3 gene, thereby causing NTDs.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-10DOI 10.1007/s00125-011-2326-yAuthors
		Y. Wu, Section on Developmental and Stem Cell Biology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USAM. Viana, Section on Developmental and Stem Cell Biology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USAS. Thirumangalathu, Section on Developmental and Stem Cell Biology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USAM. R. Loeken, Section on Developmental and Stem Cell Biology, Joslin Diabetes Center, One J...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5324423</comments>
            <pubDate>Thu, 13 Oct 2011 05:44:44 +0100</pubDate>
            <guid isPermaLink="false">5324423</guid>        </item>
        <item>
            <title>Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study</title>
            <link>http://www.medworm.com/index.php?rid=5315189&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd1122512m964k072%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Olmesartan was well tolerated but did not improve renal outcome on top of ACEI.
 
 
 Trial registration: ClinicalTrials.gov NCT00141453
 
 
 
 
 Funding: The ORIENT study was supported by a research grant from Daiichi Sankyo.
 
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-9DOI 10.1007/s00125-011-2325-zAuthors
		E. Imai, Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, Aichi 466-8550, JapanJ. C. N. Chan, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong, SAR, ChinaS. Ito, Division of Nephrology, Endocrinology, and Vascular Medicine, Department of Clinical Medicine, Tohoku University Gradu...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5315189</comments>
            <pubDate>Wed, 12 Oct 2011 16:32:23 +0100</pubDate>
            <guid isPermaLink="false">5315189</guid>        </item>
        <item>
            <title>Heterozygous ABCC8 mutations are a cause of MODY</title>
            <link>http://www.medworm.com/index.php?rid=5315190&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5mp7wu61j4l02h62%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;
 ABCC8 mutations can cause MODY in patients whose clinical features are similar to those with HNF1A/4A MODY. Therefore, sequencing of ABCC8 in addition to the known MODY genes should be considered if such features are present, to facilitate optimal clinical management
 of these patients.
 
 
 
 
	Content Type Journal ArticleCategory Short CommunicationPages 1-5DOI 10.1007/s00125-011-2319-xAuthors
		P. Bowman, Peninsula NIHR Clinical Research Facility, Peninsula Medical School, University of Exeter, Exeter, UKS. E. Flanagan, Institute of Biomedical and Clinical Science, Peninsula Medical School, University of Exeter, Exeter, UKE. L. Edghill, Institute of Biomedical and Clinical Science, Peninsula Medical School, University of Exeter, Exeter, UKA. Damhu...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5315190</comments>
            <pubDate>Wed, 12 Oct 2011 05:50:29 +0100</pubDate>
            <guid isPermaLink="false">5315190</guid>        </item>
        <item>
            <title>Erratum to: Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E</title>
            <link>http://www.medworm.com/index.php?rid=5315191&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F41p8363308768051%2F</link>
            <description>Content Type Journal ArticleCategory ErratumPages 1-1DOI 10.1007/s00125-011-2321-3Authors
		F. Fiory, Dipartimento di Biologia e Patologia Cellulare e Molecolare and Istituto di Endocrinologia ed Oncologia Sperimentale, del Consiglio Nazionale delle Ricerche, Università degli Studi di Napoli Federico II, Naples, ItalyA. Lombardi, Dipartimento di Biologia e Patologia Cellulare e Molecolare and Istituto di Endocrinologia ed Oncologia Sperimentale, del Consiglio Nazionale delle Ricerche, Università degli Studi di Napoli Federico II, Naples, ItalyC. Miele, Dipartimento di Biologia e Patologia Cellulare e Molecolare and Istituto di Endocrinologia ed Oncologia Sperimentale, del Consiglio Nazionale delle Ricerche, Università degli Studi di Napoli Federico II, Naples, ItalyJ. Giudicelli, Inse...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5315191</comments>
            <pubDate>Wed, 12 Oct 2011 05:50:27 +0100</pubDate>
            <guid isPermaLink="false">5315191</guid>        </item>
        <item>
            <title>Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice</title>
            <link>http://www.medworm.com/index.php?rid=5315192&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F353gg8787763w26j%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Chronic CB1 antagonism markedly enhances insulin-mediated glucose utilisation in DIO mice, independent of its anorectic and
 weight-reducing effects. The potent effect on insulin-stimulated BAT glucose uptake reveals a novel role for CB1 receptors
 as regulators of glucose metabolism.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-011-2302-6Authors
		M. Bajzer, Metabolic Diseases Institute, University of Cincinnati, 2140 East Galbraith Road, Building B, Room 332, Cincinnati, OH 45237-1625, USAM. Olivieri, Metabolic Diseases Institute, University of Cincinnati, 2140 East Galbraith Road, Building B, Room 332, Cincinnati, OH 45237-1625, USAM. K. Haas, Metabolic Diseases Institute, University of Cincinnati, 2140 East Galb...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5315192</comments>
            <pubDate>Tue, 11 Oct 2011 05:52:00 +0100</pubDate>
            <guid isPermaLink="false">5315192</guid>        </item>
        <item>
            <title>Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study</title>
            <link>http://www.medworm.com/index.php?rid=5315193&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr7t77887l0v53001%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;The Di@bet.es Study shows, for the first time, the prevalence rates of diabetes and impaired glucose regulation in a representative
 sample of the Spanish population.
 
 
 
 
	Content Type Journal ArticleCategory Short CommunicationPages 1-6DOI 10.1007/s00125-011-2336-9Authors
		F. Soriguer, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Spain, www.ciberdem.orgA. Goday, Department of Endocrinology and Nutrition, Hospital del Mar, Barcelona, SpainA. Bosch-Comas, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Spain, www.ciberdem.orgE. Bordiú, Laboratorio de Endocrinología, Hospital Universitario S. Carlos de Madrid, Madrid, SpainA. Calle-...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5315193</comments>
            <pubDate>Tue, 11 Oct 2011 05:51:59 +0100</pubDate>
            <guid isPermaLink="false">5315193</guid>        </item>
        <item>
            <title>Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept</title>
            <link>http://www.medworm.com/index.php?rid=5304987&amp;cid=s_33433_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F170715078p28732g%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;16S rDNA was shown to be an independent marker of the risk of diabetes. These findings are evidence for the concept that tissue
 bacteria are involved in the onset of diabetes in humans.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-7DOI 10.1007/s00125-011-2329-8Authors
		J. Amar, Inserm U1027, University Paul Sabatier, CHU, Hôpital Rangueil, Avenue Jean Pouhles, Toulouse, FranceM. Serino, Bio-Medical Research Federative Institute of Toulouse, Toulouse, FranceC. Lange, Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of Diabetes, Obesity and Chronic Kidney Disease over the Lifecourse, Villejuif, FranceC. Chabo, Bio-Medical Research Federative Institute of Toulouse, Toulouse, FranceJ. Iacovoni, ...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5304987</comments>
            <pubDate>Thu, 06 Oct 2011 06:29:29 +0100</pubDate>
            <guid isPermaLink="false">5304987</guid>        </item>
    </channel>
</rss>

